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Background: More than 25% of primary care patients are managing multiple chronic 
conditions (MCC) and 50% of their medications are not taken as prescribed. Self-
efficacy is the foundation of many successful medication adherence and chronic 
disease self-management (CDSM) interventions for specific chronic conditions. 
Interventions designed within a self-efficacy framework and tailored for the primary care 
setting could improve health outcomes for patients with MCC. Primary Aims: 1) 
Describe demographic and psychosocial characteristics of patients with MCC, 2) 
Examine the relationships between number of chronic conditions, primary (medication 
adherence) and secondary (health literacy, self-efficacy, problem-solving, and QOL) 
variables, 3) Evaluate the preliminary efficacy of a medication adherence intervention 
for patients with MCC on improving outcomes. Methods: Adult patients presenting for 
care in the Family Medicine department at a rural Federally Qualified Health Center 
were recruited to complete a survey on CDSM and participate in the intervention. The 
intervention involved 4 group sessions and 2 follow-up telephone sessions. Data 
collection occurred at baseline and post-treatment. Results: Pilot study results indicated 
that MCC was prevalent in 62% of the sample (N = 53), patients and providers generally 
had similar perceptions of CDSM needs, and better medication adherence was among 
the most frequently endorsed need. The intervention study participants (N = 20) were 
managing on average 5 chronic conditions and 40% had less than adequate health 
literacy levels. Health literacy and MCC were significantly positively associated (p = 
0.036). Outcomes analyses indicated that scores significantly improved on measures of 
Effective Problem-solving (p = .028, d = .67), Positive Transfer Problem-solving (p = 
.010, d = .67), Self-efficacy for managing chronic disease in general (p = .005, d = .66), 
and Self-efficacy for engaging in social/recreational activities (p = .005, d = .42). Self-
reported medication adherence improvements fell short of significance. Conclusions: 
Participants reported significant improvements on factors theoretically and empirically 
linked to adherence and health outcomes. Research with larger samples and longer 
follow-up is needed in order to evaluate the efficacy of this treatment and mechanisms 
for change. Collaborating with patients and providers during program development 
could facilitate acceptability and sustainability of CDSM programs.  
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Chapter 1: Introduction 
 The data consistently indicate that a significant proportion of patients seeking 
healthcare are increasingly likely to be managing multiple chronic conditions (MCC).  
Multiple chronic conditions, often referred to as multimorbidity, is commonly defined as 
the presence of more than two diagnoses of a major chronic condition (e.g. obesity, 
diabetes, high blood pressure, chronic pain, depression, etc.) (Fortin, Stewart, Poitras, 
Almirall, & Maddocks, 2012).  Boyd and Fortin (2010) reported that one in four patients 
in primary care is managing MCC, while others have reported that three out of four 
people aged 65 or older have MCC (Anderson-Rothman & Wagner, 2003; Wolff, 
Starfield, & Anderson, 2002).  In fact, the trend is increasing for patients at younger 
ages to be managing MCC (Mercer, Smith, Wyke, O’Dowd, & Watt, 2009). 
The majority of research efforts have focused on the epidemiology of this clinical 
phenomenon and its economic burden and impact on the health care system (Smith, 
Soubhi, Fortin, Hudon, & O'Dowd, 2012).  One analysis reported that individuals with 
MCC accrue, on average, $650 more per month in health care costs than those with 
less than two chronic conditions (Melek & Norris, 2008).  Patients with MCC also have 
more interaction with the health care system including higher frequency of doctor’s 
visits, hospital readmissions, and adverse events due to poor medication adherence 
(Boyd & Fortin, 2010; Starfield, 2011).  Moreover, they are more likely to be on disability 
as their ability to work is significantly compromised and they experience a number of 
psychosocial stressors (Boyd & Fortin, 2010).  In sum, living with MCC is a complex 
burden affecting patients, families, and the health care system that cuts across 
! "!
individual, community, and system levels.  Thus, efforts to address this burden need to 
be multi-faceted, collaborative, and interdisciplinary. 
Federally Qualified Health Centers (FQHCs) are one of the most common 
settings for treating and controlling symptoms of chronic conditions for many reasons.  
Primary care clinics, like FQHCs, are the point of care for the majority of patients with 
MCC (Anderson-Rothman & Wagner, 2003).  Research shows that chronic conditions 
are disproportionately present in ethnic minority groups and among rural and/or low 
income populations (Shi et al., 2013).  According to the Bureau of Primary Health Care 
(BPHC) of the Health Resources and Services Administration, to be an FQHC, a clinic 
must meet specific Medicare and Medicaid Program criteria and provide accessible 
affordable health care to medically underserved individuals.  Therefore, FQHCs 
generally reside in low-resource communities and serve patients who are low income, 
and/or are members of ethnic or racial minority groups (Taylor, 2004).  
One of the recent goals of the BPHC and its partners include reducing health 
disparities in FQHC populations by improving chronic disease self-management of its 
patients.  Self-management is defined as the day-to-day care of chronic condition(s), 
which involves many tasks related to medical and health behavior management, role 
management, and emotional management (Lorig & Holman, 2003).  When patients 
engage in good self-management practices, symptoms are better controlled, quality of 
life is improved, and the risk of complications is substantially reduced (Anderson-
Rothman & Wagner, 2002; Bodenheimer, Lorig, Holman, & Grumbach, 2002).  
Pharmaceuticals are the most common medical interventions, and particularly for 
patients with MCC, the most critical aspect of self-management is adhering to the 
! #!
prescribed medication regimen.  Medication adherence is generally defined as the 
extent to which patients follow their provider’s prescribed instructions for taking 
medications; therefore, the treatment’s effectiveness in controlling symptoms and 
preventing complications depends on patients taking their medications.  However, poor 
medication adherence is a particularly common problem as approximately 50% of 
medications for chronic conditions are not taken as prescribed (Haynes, Ackloo, 
Sahota, McDonald, & Yao, 2008; Osterberg & Blaschke, 2005). 
Recent reviews on medication adherence interventions research conclude that 
interventions are minimally to moderately effective at improving long-term adherence 
and most are impractical for use in primary care settings (Haynes, et al., 2008; 
Osterberg & Blaschke, 2005; Viswanathan et al., 2012; Williams, Manias, & Walker, 
2008).  Reviewers of self-management interventions for chronic conditions conclude 
that programs successful in changing health behaviors are typically grounded in social 
cognitive theory and should focus on improving health literacy, motivation to learn self-
management skills, problem-solving skills, and self-efficacy (Bodenheimer et al., 2002; 
Nilsen & Olster, 2013; Rothman et al., 2004; von Wagner, Steptoe, Wolf, & Wardle, 
2009).  However, research on medication adherence and self-management 
interventions traditionally involves single-disease populations and, with the increasing 
prevalence of patients with MCC, there is a substantial need for intervention research 
with this population.
Chapter II: Literature Review 
Quality of Life for Patients with MCC 
 Studies show that multimorbidity is an important independent predictor of 
adverse outcomes.  The burden of multimorbidity is associated with decreases in quality 
of life and functionality beyond the additive effects of a having a single disease (Gijsen, 
et al., 2001; Oldridge, Stump, Nothwehr, & Clark, 2001).  Thus, the first step to 
improving health outcomes is to collaborate with patients and develop a more holistic 
understanding of how multimorbidity affects patient quality of life and functionality.    
 A nationally representative prospective cohort study (N = 17,195) showed that 
patients with co-morbid diabetes, obesity and heart disease have significantly poorer 
outcomes (i.e. mobility, health service utilization, and health-related quality of life [QOL]) 
compared to those who had either condition alone or in combination with other chronic 
conditions (Oldridge, et al., 2001).  Additionally, the impact of multimorbidity on QOL 
and mortality was two to three times greater for middle-aged adults (51-61 years old) 
compared to older adults (70 years and older).  In other words, the compound effect of 
certain combinations of diseases can lead to significantly poorer outcomes than having 
either disease alone and younger individuals appear to be more affected by MCC.  
Future research needs to focus on understanding the development of MCC from a 
broader lifestyle perspective as opposed to a medically-oriented perspective (Boyd & 
Fortin, 2010).  Also, designing interventions to target improving health behaviors linked 






 Physical functioning.  Empirical evidence indicates that patients with MCC 
experience significant declines in physical functioning (Fortin et al., 2006) and physical 
well-being (Bayliss, Bayliss, Ware, & Steiner, 2004).  Bayliss and colleagues (2004) 
completed a four-year study (N =1574) assessing health outcomes of patients with MCC 
(diabetes, coronary artery disease, congestive heart failure (CHF), chronic respiratory 
disease (CRD), musculoskeletal conditions, and depression).  After four years, patients 
with four or more chronic conditions had a clinically significant decline in physical 
functioning (as measured by the physical component subscale of the quality of life SF-
36 survey; OR 2.8), after adjusting for number of chronic conditions and confounding 
variables (poverty level, gender, race, educational level, employment and marital 
status).  This change was only second to the declines reported by patients with CHF 
(OR 2.9) and it was greater than patients with diabetes (OR 2.1) and CRD (OR 1.7).   
 Psychological functioning.  Beyond affecting physical functioning, research 
has shown that having MCC affects other aspects of quality of life.  Fortin and 
colleagues (2006) reported that increases in the number of conditions and severity of 
problems caused significant declines in mental health even after controlling for patients’ 
perceived social support and a number of important demographic variables.   
Specifically, having MCC was related to significant declines in energy, social 
functioning, and role limitations caused by emotional distress.   
 Similarly, in a qualitative study, Townsend and colleagues (2003) reported on the 
experiences and self-management strategies of patients with MCC (N = 23).  Patients 
reported disruptive beliefs about self-management, disease-related distress, and 





substantial conflicting thoughts and emotional distress related to their medication 
regimen; specifically, experiencing fear of medication dependence and perceived lack of 
control over their symptoms.  Also, many reported reluctance to taking medication and 
uncertainty about its purpose and correct use of medications, suggesting limited 
understanding of their medication regimen.  Finally, patients often reported competing 
beliefs that medication facilitated one’s ability to fulfill social roles and obligations, but it 
also represented illness, loss, and a threat to one’s identity.  Subsequently, patients 
reported coping by engaging in various maladaptive and self-regulation strategies such 
as, minimizing medication use, avoiding medications, creating complex schedules for 
remembering their regimen.  Collectively this research suggests that distress and 
uncertainty patients report about the medication regimen is associated with perceived 
lack of control over one’s body, maladaptive coping, and low confidence in managing 
one’s health. 
 In sum, the day-to-day management of MCC and frequent interactions with the 
health care system has a significant negative influence on one’s quality of life.  The 
physical and psychosocial problems (e.g. polypharmacy, emotional burden, compound 
effects of diseases) reported by patients appear to be associated with the burden of 
managing the complex medication regimen in particular.  Yet more research is needed 
to better understand how having MCC affects one’s self-efficacy for self-management, 
psychological well-being, and life satisfaction.
Common Adherence Tasks and Barriers in Treatment for MCC 
The goal for treatment when managing MCC, regardless of the chronic 





premature mortality.  The most common approach involves prescribing a new 
medication(s) and titrating old medication(s) (Nace, Grundy, & Nielson, 2012).  
Regardless of the type or number of chronic conditions, patients are responsible for 
adhering to the medication regimen, self-monitoring symptoms and medications side 
effects, and keeping regular medical appointments (Clark et al., 1991; Paharia, 
2008).  Level of health literacy affects actions and decisions patients make in regard 
to following their medication regimen (Nutbeam, 2000; von Wagner et al., 2007).  
Similarly, regardless of number and type of chronic conditions patients experience 
common challenges or barriers to adhering to their medication regimen (Bayliss, 
Ellis, Steiner, 2007).  Notably, research shows that when patients have adequate 
knowledge, skills, and confidence their self-efficacy for engaging in self-
management tasks and ability to problem-solve barriers improve.  These 






Table 1  
Commonalities in Treatment for MCC: Medication Adherence 
Adherence Tasks Barriers to Adherence 
• Medication Regimen 
o Understand prescriptions  
o Fill prescriptions 
o Create dosing schedule 
(amount, sequence, timing) 
o Make dosing adjustments 
when recommended 
o Regularly take medications 
• Self-monitoring 
o Biomarkers for each condition 
o Side effects and symptoms 
o Accurately interpret 
symptoms 
• Regularly communicate with 
provider  
• Attend appointments 
• Limited health literacy 
o Limited numeracy and oral 
and reading literacy 
o Lack of basic knowledge 
related to chronic conditions 
• Psychological factors 
o Low self-efficacy 
o Psychopathology  
o Disruptive beliefs about health 
o Disease-specific distress 
o Maladaptive cognitive and 
behavioral coping styles 
• Sociodemographic factors 
o Limited education 
o Low socioeconomic status 
o Limited access to services 
and health insurance 
 
Usual care treatment.  The Institute of Medicine (IOM, 2012; Nilsen & Olster, 
2013) only recently began developing treatment guidelines for patients with MCC.  
These new initiatives are encouraging, in that that they move away from treating 
patients on a disease-by-disease basis to improving patient’s quality of life and 
optimizing health outcomes (Department of Health and Human Services, 2010).  
Consistent with this patient-centered approach and given that mental health 
problems and psychosocial stress are associated with and exacerbate medical 
conditions, it is also recommended that the treatment team, patient, and family 
assess, monitor, and manage the psychosocial sequelae.  However, since the new 





implemented into some settings, particularly rural and low resource primary care 
clinics, many providers continue to follow guidelines using the single disease 
approach.   
Adherence to medication regimen.  Once diagnosed with one or more 
chronic conditions patients begin a pharmacotherapy regimen to help manage or 
control symptoms, prevent complications, and decrease risk of comorbidities.  
Research has shown that in single-disease populations, medication taking is more 
easily followed than making lifestyle changes (Gonder-Frederick, Cox, & Ritterband, 
2002).  Nonetheless, 50% of medications are not taken as prescribed (Haynes, et 
al., 2008).  The consequences of poor adherence are severe and costly as patients 
with poor adherence are more likely to be hospitalized for preventable reasons, have 
greater visits to the emergency department, and increased risk for complications, 
morbidity, and mortality (Stuart & Briesacher, 2002).  Alternatively, good adherence 
slows disease progression and reduces health care costs.  In fact, in a recent review 
of outcomes for 11 chronic diseases, Boswell and colleagues (2012) reported that 
improvements in adherence resulted in improvements in 81% (64 out the 71) of 
clinical outcomes evaluated.   
For patients with MCC, medication adherence is more challenging due to the 
complexity of the regimen and increased risk of medication side effects and 
interactions.  In fact, an average of 50 prescriptions are filled each year among 
Medicare beneficiaries with MCC.  Also as the number of medications and/or chronic 
conditions increases adherence declines (Roter, et al., 1998).  Research shows that 





quality of life, beliefs about medications, provider communication, issues with the 
health care system, and sociocultural influences, (Krousel-Wood, et al., 2004).  For 
example, in one study, Hill-Briggs and colleagues (2008) investigated medication 
adherence of low-income African American patients with co-occurring diabetes, 
hypertension, and high cholesterol.  Patients reported that the most common 
reasons for poor adherence were running out of medications and forgetting to take 
medications and that poor adherence was less of problem.  Notably, both patients 
and providers often have limited insight in identifying poor adherence (Osterberg & 
Blaschke, 2005).  The provider tries to control symptoms by changing the medication 
regimen which may increase its complexity and potentially have negative effects on 
the patients including, feelings of uncertainty and beliefs that the patient has little 
control over their body.  Perhaps improving health literacy and increasing patient 
insight about their current medication taking behavior and adherence rates through 
self-monitoring will improve their confidence in self-management and perceived 
control over their regimen.   
Adherence to self-monitoring and symptom interpretation.  Another self-
management task recommended by providers and shown to improve health 
outcomes are daily self-monitoring and accurate interpretation of symptoms (Clark et 
al., 1995).  Regular self-monitoring of physical and mental health symptoms 
decreases the risk for many complications and additional diagnoses by as much as 
75% (Wysocki, 2006).  Patients are expected to learn and interpret important 
biomarkers such as normal blood glucose levels before and after meals, blood 





Together self-monitoring and accurate symptom interpretation help patients 
learn about their baseline levels, fluctuations over time, reactions to recent changes 
in the internal or external environment (e.g. changes in medication, physical activity, 
diet, stress etc.).  Moreover, these measures often provide important information 
such as, reinforcement that their symptoms are well managed, a cue to take 
medication, or that they are experiencing side effects and/or need to contact their 
provider.  Finally, accurate symptom interpretation enables the patient to problem 
solve and take immediate action when problems arise which can prevent 
unnecessary stress and hospitalizations.  However, these tasks can be difficult for 
many patients as one’s experience is confounded by limited health literacy (von 
Wagner, et al., 2009), interactions between medications, stress, symptoms from co-
occurring conditions, and changes in physical activity and diet (Townsend et al., 
2003).  
Adherence to attending medical appointments. To prevent or reduce the 
likelihood of long-term complications, it is also recommended that the patient, and if 
possible the family, regularly attend follow-up visits to their primary care provider and 
appropriate specialty providers. However, due to the fragmentation of health care 
and economic limitations of many patients with MCC, maneuvering this system can 
be overwhelming for patients.  Notably, new initiatives of the Department of Health 
and Human Services (HSS) aim to overcome these barriers by: “1) strengthening the 
health care and public health systems, 2) empowering the individual to use self-care 
management, 3) equipping health care providers with tools, information, and other 





effective interventions” (HHS, 2010).  Subsequently, the Institute of Medicine began 
developing treatment guidelines for patients with MCC and funding agencies have 
begun aligning research programs in order to fill gaps in knowledge about health-
care and self-management of MCC (Nilsen & Olster, 2012).   
In sum, patients with MCC, medication management is the most common 
approach to treatment in primary care.  Adequate medication adherence requires 
patients to increase their health-related knowledge and develop good self-
management skills.  Specifically, patients should have adequate knowledge of 1) 
how appropriate medication adherence can decrease risk for complications, 2) the 
prescribed regimen, 3) medication side effects, and 4) disease-specific information 
(e.g. normal glucose levels, symptoms).  Additionally, patients should understand 
how to translate this knowledge into self-management tasks including making 
lifestyle changes to ensure consistent medication taking (i.e. proper dose, sequence, 
and timing) and daily self-monitoring (i.e. symptoms and side effects) as well as 
attending regular visits with their provider(s).  Finally, due to the frequent 
adjustments providers make to medication regimens, patients would benefit from 
adopting a flexible approach to taking their medications.
Barriers to Medication Adherence 
Adherence has continued to decline despite improvements in pill design (e.g. 
color, shape, schedule, and administration method), medication efficacy, and public 
availability of information on medication (Cook, 2007).  This decline suggests that 
patients face other barriers to adhering to their medication regimen such as, limited 





(Cook, 2007; Glasgow, Toobert, & Gillette, 2001).  This section will focus specifically on 
factors that are likely to be amenable to intervention.   
Limited health literacy.  Health literacy is a critical set of skills for engaging 
in daily self-management of one’s health and significantly influences one’s ability to 
function in the health care environment.  The concept of health literacy has evolved 
particularly since the turn of the century (Edwards et al., 2012; Institute of Medicine, 
2004; Jordan et al., 2010; Nutbeam, 2000; von Wagner, 2007).  A comprehensive 
definition developed from this research defines health literacy as the cognitive and 
social skills essential for gaining access to, understanding, and using health-related 
information to maintain good health (Nutbeam, 2000).  Adequate health literacy thus 
requires one to also have adequate basic literacy including numeracy and oral and 
written literacy.  Health literacy also overlaps with the concept of self-management 
as both refer to skills necessary for good medication adherence, regular self-
monitoring, and seeking and interacting with health care services.  Given these 
similarities, the measurement of the construct of health literacy has engendered 
significant empirical scrutiny and researchers have found that multiple factors (e.g. 
health care population, setting, and self-management tasks) need to be considered 
when assessing one’s level of health literacy (Smith, Nutbeam, McCaffery, 2013).   
Some investigators theorize that limited health-related knowledge creates 
motivational and volitional barriers for adherence (von Wagner, et al. 2009).  Indeed, 
low health literacy has been implicated at all levels of health care from poor self-
management to higher overall health care costs and increased risk for morbidity and 





2009).  At the level of self-management, individuals with limited health literacy are 
less likely to take medications appropriately, accurately interpret printed health-
related and medication information, and communicate effectively with their providers 
(Berkman, et al., 2011).  Not surprisingly, data from a population-based study of 
Medicare recipients indicated that individuals with poor health literacy have 
significantly higher rates of hypertension, diabetes, heart failure, arthritis, and 
depression compared to individuals with adequate health literacy (Wolf et al., 2005).  
Drawing from current research, it is hypothesized that patients with MCC and limited 
health literacy experience compounded difficulties in adhering to the complex 
medication regimen.   
Low self-efficacy.   Self-efficacy has been shown to predict a wide-range of 
health behaviors in patients with chronic conditions, including medication adherence 
(Bandura, 1997; Elliott, 2008; Marks, Allegrante, Lorig, 2005; Schoenthaler, Ogedegbe, 
& Allegrante, 2009; Wolf et al., 2007).  Self-efficacy is a cognitive-behavioral concept 
and is commonly defined as the confidence one has in his/her ability to perform a task 
or change his/her thinking, regardless of potential challenges in the environment 
(Bandura, 1986).  According to social cognitive theory (Bandura, 1997), patients with 
high self-efficacy and positive outcome expectancies are more likely to take 
responsibility for their health and engage in health promoting behaviors.  Indeed, 
individuals with high levels of self-efficacy and those that report improvements in self-
efficacy have better health outcomes and accrue lower health care costs (Barlow, 
Wright, Turner, & Bancroft, 2005; Barlow, Wright, Sheasby, Turner, & Hainsworth, 2002; 





medication adherence means having confidence to take medications as prescribed 
across a variety of situations such as during times of psychological, social, and 
economic stress or after adjustments are made to the regimen, despite having side 
effects or when asymptomatic.  Alternatively, patients with low self-efficacy are more 
likely to avoid taking medications or only partially adhere during these times. 
Although self-efficacy has been widely studied within the context of self-
management of chronic conditions, only a few studies have investigated the 
influence of self-efficacy on medication adherence.  Nonetheless, perceptions of 
self-efficacy appear to be an important mediator in medication adherence (Brus, van 
de Laar, Taal, Rasker, & Widgman, 1998; Ogedegbe, Mancuso, Allegrante, & 
Charlson, 2003; Wolf et al., 2007).  Among patients with arthritis (N = 37) taking a 
slow-acting drug (i.e. effects occur only after weeks or months of continuous use), 
self-efficacy, compared to other important demographic variables, perceived 
barriers, perceived support, and disease-related variables, was the only factor that 
distinguished between good compared to poor adherence (Brus et al., 1998).  Good 
adherence in this study was considered at least 80% adherence as measured by a 
pill counting procedure.   
Additionally, self-efficacy appears to be an important mediator between health 
literacy and adherence.  In a study with patients with HIV, Wolf and colleagues 
(2007) reported that self-efficacy mediated the impact of low health literacy on 
medication adherence.  Like the medical regimen for HIV patients, the regimen for 
MCC involves taking multiple medications on different dosing schedules.  This 





patients with MCC and limited health literacy improve their medication adherence.  
However, research on the relationship between self-efficacy, health literacy, and 
self-management skills is largely disease specific and little is known about their 
relationship in the context of self-management of MCC. 
Psychological factors.  There appears to be a bi-directional relationship 
between mental health problems and most prevalent chronic diseases like heart 
disease and diabetes.  In fact a recent meta-analysis found that individuals with 
depression are at a significant risk of developing chronic conditions (relative risk for 
diabetes =1.6; Mezuk, Eaton, Albrecht, & Golden, 2008).  On the other hand, having a 
chronic condition or acute events related to chronic disease (e.g. myocardial infarction) 
places individuals at a greater risk for developing major depression (Mezak, et al., 2008; 
Spijkerman, et al., 2005).  Regardless of which developed first, depression or chronic 
medical illness, large-scale epidemiological studies have shown that the presence of 
psychopathology, particularly anxiety and depressive disorders, substantially increases 
the risk of all-cause mortality (Sullivan et al., 2012).   
The symptoms of depression (e.g. loss of energy, poor concentration, depressed 
mood) and psychological sequelae make it particularly challenging for individuals with 
MCC to improve their health literacy and adhere their medication regimen over long 
periods of time.  Further, even patients with sub-clinical symptoms are at risk because 
their depression may go undetected which results in inadequate treatment or follow-up 
(Hayes, Wells, Sherbourne, Rogers, & Spritzer, 1995).  Subsequently, as severity of 
depression increases, patients report more functional limitations and declines in quality 





disease severity, and number of co-occurring conditions, individuals with clinical 
depression or even subthreshold depression report significantly poorer health literacy, 
physical functioning, perceived health status, quality of life and social support as much 
as or greater than patients with chronic medical conditions (Edwards, et. al, 2012; Fortin 
et al., 2006; Hays et al., 1995; Noel et al., 2004).  For example, Hill-Briggs and 
colleagues (2005) reported that low-income African American patients with clinical 
depression disproportionately struggled with adhering to their medication regimen 
compared to nondepressed patients. 
Additionally, research has consistently shown that, aside from the presence of 
depression, health-related distress can negatively affects one’s self-management 
abilities (Gonzalez, Fisher, & Polonsky, 2011).  For example, dysfunctional, unrealistic, 
and/or negative thoughts about one’s health and self-management abilities (e.g. 
“Nothing I can do can change my health” or “I feel fine, therefore I don’t need my 
medication or to check my blood pressure today” or “I’m defective/weak/broken.”) 
negatively affects one’s self-efficacy and adherence, thus maintaining an unhealthy 
lifestyle (Beck, 2011; Ogedebe, et al., 2003).  Indeed, maladaptive coping behaviors, 
such as avoidance, social withdrawal, and substance use, are common in patients with 
depression and adjustment problems and lead them to disregard treatment 
recommendations or avoid learning about their illness or taking their medication (Cook, 
2007).  Programs that include cognitive and behavior based coping strategies that 
explore and address these factors would help improve patient engagement in self-
management. 





sociocultural factors on health outcomes, health care access, and treatment adherence 
rates.  Results from studies in low-resource primary care settings report that minority 
patients are less likely to have access to primary care and have health insurance 
compared to non-Hispanic White patients (Shi et al., 2013).  However, other research 
suggests that socioeconomic factors, like socioeconomic status and race do not 
significantly impede medication adherence in chronic conditions (Dimatteo, 2004) and 
that at least 60% of low income patients are adherent (Cook, 2007).  Nonetheless, this 
still leaves a large portion of patients who do not adhere to their medication regimen. 
Factors associated with ethnic minority or low income groups, like lower 
educational attainment, may help account for greater risk of chronic disease diagnoses 
and stronger barriers to adherence.  In the 2007 National Health Disparities report 
Hispanics were 4.6 times and African Americans were almost three times more likely 
than Whites to have below basic health literacy levels as measured by the National 
Assessment of Adult Literacy (Kutner, Greenberg, Jin, & Paulsen, 2006).  Adapting 
interventions and intervention materials for limited literacy and limited health literacy 
populations may help improve medication adherence.  For example, improving 
numeracy skills and understanding of oral and written information about health 
outcomes can enhance patients’ knowledge and motivation to adhere to a medication 
regimen as well as help improve their ability to seek and obtain services and health 
insurance (Kuhajda, Thorn, Gaskins, Day, & Cabbil, 2011; von Wagner et al., 2009).   
Poor social support is also a substantial barrier to medication adherence 
(Glasgow et al., 2001; Townsend et al., 2003).  For example, one’s medication dosing 





facilitate (or impede) the change process necessary for improving adherence.  Although 
it often may not be feasible for self-management programs to include families, programs 
can offer training for improving communication skills and help patients become better 
utilizers of their support system. 
 Single-disease approach to health care.  The current disease-oriented 
approach to health care creates many barriers for patients with MCC in regard to getting 
their needs met (Mercer, et al., 2009).  Interactions with the health care system become 
inextricably more complex and difficult when managing multimorbidity (Boyd & Fortin, 
2010).  For instance, patients are expected to maintain appointments with primary care 
and specialty providers, who are located at various clinics that are not always in the 
same community.  This can be particularly difficult for patients with limited resources, 
limited access to care, or multiple psychosocial stressors.   
In sum, a few conclusions can be drawn from this review of barriers to 
medication adherence.  Research from the single disease literature on medication 
adherence consistently indicates that poor self-efficacy and cognitive and behavioral 
factors have the strongest impact on medication adherence.  Future research should 
address ways interventions can help patients overcome these barriers.  Therefore, the 
following will evaluate the current state of the research on medication adherence 
interventions and, where appropriate, self-management interventions for specific 
chronic conditions.  
Medication Adherence Interventions for Patients with MCC 
Although managing multimorbidity has long been a task of the clinical 





relatively new to the research community.  Reviews of the literature indicate that the 
majority of approaches for improving medication adherence focus on disease-specific, 
education-based interventions in primary care settings (Haynes et al., 2008; Osterberg 
& Blaschk, 2005; Viswanathan et al., 2012).  These programs are designed to provide 
patients with knowledge about their medications, dosing schedules, and disease-related 
information and patients determine whether or not to use this information in their daily 
lives.  Although didactic models can bring awareness to the importance of behavior 
change, the data do not suggest that this approach is effective in facilitating behavior 
change and improvements in medication adherence and health outcomes.  This is 
consistent with reviews of education-based interventions for disease-specific self-
management programs for socially disadvantaged populations (Glazier, Bajcar, Kennie, 
Willson; 2006; Plack, Herpertz, & Petrak, 2010) and patients with MCC (Smith et al., 
2012).   
This is likely due to the fact that educational approaches do not attend to the 
multifaceted needs that characterize many patients with MCC including limited health 
literacy, poor self-efficacy, significant distress, or limited access to health care.  They 
also do not attend to the unique aspects associated with managing MCC including the 
regimen complexity, medication interactions, and managing side effects.  Thus, 
education-based interventions may be necessary, but they are not sufficient.  It is likely 
that interventions for medication adherence would have greater success if they 
combined education and strategies for helping patients overcome psychosocial barriers. 
Reviews of clinical trials evaluating medication adherence interventions for 





review of randomized clinical trials (RCTs) (N = 8) available, while another review 
reported on a subset of interventions for MCC (n = 3; Viswanathan et al., 2012).  
Interventions were primarily pharmacist-led and used brief didactic and/or behavioral 
methods which included providing education, identifying medication-related problems, 
creating reminder charts, simplifying the regimen, and providing referrals.  Nonetheless, 
the majority of adherence interventions were ineffective and studies had low power, 
therefore reviewers concluded that the evidence is insufficient and more research with 
patients with MCC is needed. 
De Geest and colleagues’ (2006) completed a unique pilot study with patients 
with MCC that investigated the effects of a self-efficacy driven intervention on 
medication adherence.  The intervention used a combination of strategies including 
education, problem-solving and goal-setting training with targeted feedback to increase 
self-efficacy.  The approach involved one home visit and three monthly follow-up 
telephone sessions.  Patients (N = 13) exhibited improved adherence, as measured by 
an automated pill counting device in the pill bottle caps; however, they were unable to 
maintain improvements at follow-up.  Although this approach is evidence-based and 
used both educational and behavioral approaches, modifications in intervention dose or 
frequency or specific strategies are needed to facilitate long-term improvements in 
adherence.  Further, as previously discussed, psychological distress specific to taking 
multiple medications is common among patients with MCC, yet current interventions 
rarely address this aspect of adherence.   
Relatively more medication adherence studies with disease-specific populations 





methods (Cook, 2006; Haynes et al., 2012; Vasanwanthan et al., 2012).  A meta-
analysis completed by Cook (2000; as cited in Cook, 2007) reported interventions with 
the greatest effect sizes include a combination of educational and psychosocial 
strategies (mean d = 0.74) with self-monitoring (d = 1.09) cognitive behavioral therapy 
(d = 0.97), and assertiveness training (d  = 0.74) having the strongest effects on 
adherence behaviors.  Additionally, a Cochrane review using qualitative analyses 
concluded that interventions successful in improving adherence had frequent 
interactions with patients (i.e. one contact per week) and included long term follow-up (> 
6 months).   
Notably, one pilot trial evaluated how an individualized integrated care approach, 
designed for a primary care setting, improved medication adherence in patients with 
depression and type 2 diabetes (Bogner & de Vries, 2008).  A care manager served as 
the interventionist and as a liaison between patients and providers.  The brief four week 
program included three 30 minute in-person sessions and two 15 minute telephone 
monitoring sessions.  Patients exhibited significant improvement in medication 
adherence, as measured by automated pill counting device, with the intervention group 
achieving greater than 80% adherence.  However, follow-up data were not collected in 
this sample, thus the long-term effectiveness of this approach is unknown. 
Also, research on general self-management interventions for patients with MCC 
could provide insight into potentially effective methods for adherence interventions.  
Although this research is only just beginning, a recent review of RCTs (N =10; Smith et 
al., 2012) reported that interventions with improved psychosocial outcomes (e.g. quality 





behavioral coping strategies, self-management skills training, and structured feedback.  
Also programs associated with the medical clinic and tailored to specific patient 
concerns had greater success than those in the community or ones that had preset 
goals.  No studies in this review (Smith et al., 2012) directly intervened on medication 
adherence indicating a significant gap in research on MCC. 
The Chronic Disease Self-Management Program (CDSMP) is a particularly 
successful intervention for patients with MCC (Lorig et al., 1999, 2005).  The 
intervention was grounded in social cognitive theory and aims to improve self-efficacy 
through use of cognitive symptom management techniques, dealing with emotions of 
fear, anger, and depression, communication with others (family, health care 
professionals), problem-solving, and decision making.  The intervention was a peer led 
group program that met weekly for 2.5 hours for seven weeks.  At one year follow-up 
participants reported significant reductions in health distress and health care utilization 
and improvements in stress management, self-efficacy, and disability.  Notably, after 
controlling for demographic variables, baseline levels and changes in self-efficacy were 
related to health-care utilization and engagement in one’s daily self-management tasks.  
This research is consistent with single-disease literature, which indicates that programs 
that aim to improve self-efficacy results in better self-management.  Although this 
program is impractical for the primary care setting, aspects of the program (i.e. using a 
group method and combination of strategies) would likely be helpful in facilitating 
medication-related behavior change. 
In conclusion, the evidence for interventions for medication adherence is weak 





method.  A significant gap in the research is the paucity of studies that are theoretically 
grounded and designed to help patients with MCC overcome known barriers  to 
medication adherence (e.g. limited health literacy, poor self-efficacy, psychological 
distress).  Based on current research, recommendations for further intervention, 
development, and clinical research on medication adherence in patient with MCC are 
listed below: 
1. Interventions for should be grounded in theory and build on and apply 
available evidence for effective single-disease medication adherence and 
self-management interventions.   
2. Common barriers associated with managing MCC should be addressed in 
interventions including medication regimen complexity, distress, and poor 
self-efficacy and interventions should be tailored to patients with limited health 
literacy. 
3. To meet the unique needs of patients with MCC, interventions should include 
an integration of educational, cognitive, behavioral, and emotional strategies.  
Importantly, goals should be collaborative with consideration of patient values 
and concerns and follow-up on progress with goals should include problem-
solving and structured feedback. 
4. Outcome measurement should be prioritized and addressed in the early 
stages of intervention development.  Outcomes to consider include a 
combination of measures of adherence, as well as measures that assess 
variables that influence other aspects of managing MCC including, self-





5. Patients with MCC are commonly seen in FQHCs or low resource primary 
care settings.  Thus, interventions should be designed with consideration of 
the unique needs of these settings.  
Self-Efficacy as a Framework for Interventions 
Self-efficacy, the primary construct of social cognitive theory (Bandura, 1986), is 
the foundation of many successful programs in medication adherence and self-
management interventions in disease specific studies and the effectiveness of using this 
model in interventions for patients with MCC is building.  Nonetheless, self-efficacy is a 
complex concept and researchers have only recently begun elucidating the specific 
social, cognitive, behavioral, and emotional mechanisms that improve self-efficacy and 
maintain long term behavior change. 
In theory, self-efficacy is the link between a patient knowing what to do and 
actually doing it (Bandura, 2002).  Bandura (1997) asserts that self-efficacy is 
determined and influenced by one’s history of successfully doing a task, observing 
others accomplish a task, and other’s verbal persuasion to engage in a task.  Research 
with patients with chronic conditions indicate that cognitive strategies aimed at 
improving confidence improve one’s perception of his/her ability to carry out a task and 
behavioral activation strategies can facilitate engagement in self-management tasks 
(Marks, et al., 2005a, 2005b).  Further, the more one engages in self-management 
tasks and learns from past experience, the more confidence one has to overcome 
problems that impact self-management.  Applied to medication adherence interventions, 
it is hypothesized that programs that include education, training in cognitive-behavioral 





Improvements in self-efficacy for a measureable task like medication adherence could 
also potentially generalize to improving confidence for engaging in other self-
management tasks.   
Figure 1 below depicts an evidence-based model for improving medication 
adherence in patients with MCC by targeting self-efficacy, specifically through 
improvements in three domains of self-efficacy.  Figure 1 provides an overview of the 
knowledge, cognitive and behavioral targets for improving self-efficacy for medication 
adherence.  Each domain and specific strategies for improving self-efficacy are 
discussed in the corresponding sections below.  It should be noted that strategies 
identified as primarily falling under one domain are also likely to facilitate improvements 
in other domains, which collectively enhances self-efficacy.  Thus, domains of self-



















Figure 1. Intervention targets for improving self-efficacy for medication adherence. 
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Improving self-efficacy: Knowledge.   Successful adherence to a complex 
medication regimen requires understanding of basic health information and how to 
integrate information about medications and health conditions amidst the competing 
needs of one’s lifestyle.  Therefore, patients taking multiple medications for MCC need 
to be literate at multiple levels from having basic numeracy skills for calculating and 
sequencing multiple medications) to knowledge about medications and health 
conditions to knowledge about how to obtain financial assistance for medications (e.g. 
insurance, medication assistance programs).   
Nutbeam (2000) proposed a multi-level model for health literacy that provides a 
framework for designing interventions for improving each level of health literacy.  Level 
1, functional health literacy, refers to factual health and disease-related knowledge as 
well as knowing how to use the health care system.  Interventions for medication 
adherence can initially improve functional health literacy by helping patients create a 
schedule for the dose, frequency, and sequence of their medications, provide interactive 
exercises to practice making adjustments to the regimen, and encourage patients to 
work with their provider to simplify their regimen.  Further, group programs provide 
valuable experiential learning opportunities about others experiences with working with 
providers, maintaining adherence through stressful situations, obtaining clinic and 
community services. 
Although it is common for interventions to provide disease-specific and 
medication-specific education, it would be impractical to provide all of this information 
for patients with MCC.  In fact one review of medication adherence interventions 





intervention (Conn, et al., 2009).  However, Conn and colleagues reported that 
interventions that include succinct written instructions for taking medications were more 
effective (mean d = 0.61) compared to those without instructions (mean d = 0.29).  
Programs, therefore, may be more effective through helping patients improve their 
information seeking skills such as how to discern relevant information from prescription 
inserts and how to create dosing schedules as well as encourage patients to express 
concerns and questions to their pharmacist or provider about directions for medication 
taking.  Programs can also help patients learn how to connect with available medication 
assistance programs in their clinic. 
 Level 2, interactive health literacy, of Nutbeam’s model (2000) is the 
development of essential cognitive, behavioral and social skills and application of these 
skills to improve knowledge, motivation, and self-confidence for managing health.  The 
skills associated with this level are typically taught in self-management programs for 
improving behavioral outcomes and therefore discussed in the next section.  Finally, 
level 3, critical health literacy, is the development of cognitive skills for understanding 
social and political action in the community and societal determinants of health, thus is 
linked to population benefit.  Some aspects of critical health literacy can be improved 
through medication adherence intervention such as helping patients understand their 
right to services and the costs and benefits of recommended services.  Research 
suggests that patients move back and forth through the levels based on their health 
status and involvement in decision-making (Smith et al., 2013), therefore it is important 
for programs to provide some flexibility to individualize interventions based on patient 





 As previously discussed, patients with MCC and limited health literacy may also 
have limited basic literacy skills.  Therefore, discussions and materials should be 
tailored to the needs of these patients.  The National Institutes of Health (NIH, 1994) 
Checklist of Key Principles of Effective Low-Literacy Print Materials is a resource that 
can be used to guide adaptations to materials in regard to their content and style, 
layout, visuals, and readability.   Some examples of the guidelines include using simple 
diagrams or pictures, breaking large amounts of information down into small chunks, 
simplifying language, and creating straightforward instructions (i.e. “how-tos”).  
Additionally, the educational component of each session should cover one or two 
important concepts with a limited number of handouts rather than providing pages of 
text on multiple health-related concepts.  These modifications will enhance 
comprehension as well as decrease feelings of being overwhelmed or burdened by 
information. 
 Improving self-efficacy: Cognitive skills.  Bandura (1986) asserts that the 
likelihood of participating in a behavior is dependent upon one’s perceived ability to 
overcome barriers and achieve success as well as one’s expectations about the 
outcome of that behavior.  Patients with MCC express uncertainty and have conflicting 
beliefs about their ability to manage their medications as well as associate negative 
feelings with taking medication (McSharry, Bishop, Moss-Morris, & Kendrick, 2012).  
Improving self-efficacy, thus, requires an understanding of how confidence in one’s 
ability to engage in daily self-management can be enhanced and how uncertainty and 





Leventhal and colleagues’ Common Sense Model (1980, 2011) asserts that 
when deviations are detected in mental and physical functioning from expected 
functioning, one attaches meaning to the deviation referred to as a cognitive and 
emotional representation.  Representations are determined by individuals’ current 
knowledge about their health, social comparisons, and past experiences and are used 
to monitor health threats and guide self-management efforts.  It is expected that by 
increasing knowledge about chronic conditions and medication regimen, uncertainty will 
decline and self-confidence will improve.  Specifically, when patients learn about the 
symptoms of their diseases, medication side effects, and personal signs of stress, their 
ability to interpret and manage symptoms will likely improve.  Subsequently, individuals 
will attach adaptive representations to deviations in functioning and their confidence to 
respond appropriately and overcome problems will improve.  Indeed, research shows 
that patients have greater confidence in their ability to take medications appropriately 
when they have a clear understanding of their regimen and adherence goals (McSharry 
et al., 2012). 
Patients also have conflicting beliefs about taking their medication, which affects 
their confidence to engage in the recommended regimen.  For example, McSharry and 
colleagues (2012) investigated the cognitive representations of patients with MCC and 
found that patients understand that their medication regimen helps them function 
normally, but it reminds them of their illness which represents a threat to their identity.  
This conflict is similar to that of patients involved in qualitative research by Townsend 
and colleagues (2003).  Notably, discussion in a group setting can help patients 





learning evidence-based cognitive strategies can help patients address and resolve 
discrepant representations about their health and self-management regimen. 
Confidence is also affected when patients feel overwhelmed and struggle with 
managing their medication regimen.  As providers attempt to pharmacologically control 
symptoms and prevent complications, they typically prescribe more and make 
adjustments to current prescriptions.  As a result, patients attempt to accommodate their 
lifestyle to their evolving medication regimen and changing health status, thus, the 
complexity of the regimen is burdensome.  Essentially, taking medication becomes 
associated with negative emotions and perceived loss of control over their routine, 
lifestyle, and body (McSharry et al., 2012; Townsend et al., 2003).  Research indicates 
that when emotional barriers (or maladaptive representations) are addressed patients 
are better equipped to solve daily problems associated with managing chronic 
conditions (Krichbaum et al., 2003). 
 Improving self-efficacy: Behavioral skills.  The final domain for improving self-
efficacy and self-management is learning behavioral skills.  The majority of medication 
adherence interventions that incorporate a behavioral component often use specific 
strategies like setting reminders, simplifying the dose regimen, and using medication 
packaging options (e.g. pill organizers and labeled boxes).  In fact, one review (Conn et 
al., 2009) reported that the most effective behavioral strategy used with older adults was 
medication packaging.  Interventions that used this strategy were associated with larger 
effect sizes (mean d = 0.67) compared to those without that option (mean d = 0.33).  
This section below will discuss broader theoretically grounded approaches that can 





potentially be generalized to other self-management tasks.  Given the multifaceted 
needs of patients with MCC it seems particularly critical to provide training that is 
generalizable to other self-management tasks. 
 Self-Monitoring.  Substantial research suggests that people can not increase 
their motivation to change or create sustainable change without an adequate 
understanding of their current patterns and the psychosocial factors influencing them 
(Bandura, 1991).  Self-monitoring provides individuals with feedback about their own 
behavior and barriers to self-management.  Self-monitoring is commonly taught in self-
management interventions and interventions that include this strategy are significantly 
more effective (mean d = 1.18) compared to interventions that do not include self-
monitoring (mean d = 0.30) (Conn et al., 2009; Haynes et al., 2008).   
 Bandura’s (1991) research indicates that the act of self-monitoring can lead to 
behavior modification and increase perceived locus of control over one’s health.  
Applied to medication adherence, collecting personal data on medication taking 
behavior, symptoms, and side effects directly engages patients and provides valuable 
feedback on daily patterns that can be used for setting realistic and achievable goals.  
Additionally, in the case of multiple medications, self-monitoring may provide 
information on how to simplify the regimen.  Reflecting on personal medication logs and 
sharing with others personal successes and barriers is therapeutic because patients 
can express beliefs about self-management, learn how to self-assess by acknowledging 
personal strengths and identifying opportunities for improvement, and learn from others’ 





adherence, it can generalize to other self-management tasks that require lifestyle 
modifications (e.g. diet, physical activity). 
 Goal setting for medication adherence.  According to SCT and health behavior 
change research, goal setting and achievement is a fundamental element that 
significantly contributes to positive behavior change (Bandura, 1997, Bodenheimer & 
Handley, 2009; Marks et al., 2005b).  The simple underlying assertion is that as people 
achieve their goals, their self-efficacy improves; alternatively when people fail to achieve 
their goals their self-efficacy goes down and they abandon their behavior change 
efforts.  Indeed the US Preventative Services Task Force, American Diabetes 
Association, and American Heart Association all consider goal-setting a critical skill to 
managing chronic conditions and preventing disease-related complications 
(Bodenheimer & Handley, 2009).  However, interventions for structured goal setting 
have yet to be incorporated into studies for improving medication adherence. 
 Because goal-setting is typically a component of a broader intervention, research 
on specific goal-setting strategies for health behavior change is still in its early stages.  
Health-related interventions vary in the quality and magnitude of the goal-setting 
practices, with goals being general (e.g. improve medication adherence) or specific with 
a detailed action plan (e.g. improve adherence by using reminder cues to take diabetes 
medication every day, before breakfast).  A review of research of goal-setting 
approaches in primary care settings indicates that successful interventions typically 
encourage patients and providers to collaboratively create specific short-term goals and 
interventionists follow-up with patients to provide structured feedback (Bodenheimer & 





 The small changes model (SCM) is a theory-based behavioral approach that 
incorporates self-monitoring and goal-setting strategies for improving weight 
management (Lutes & Steinbaugh, 2010; Sbrocco, Nedegaard, Stone & Lewis, 1999).  
According to the SCM, when specific goal setting criteria are met, self-efficacy for 
making continued lifestyle changes increases and weight loss is more sustainable.  
Goals must be relative to one’s baseline levels, therefore patients are asked to self-
monitor and self-select goals based on current behavioral patterns.  Goals must be 
realistic or manageable so that the patient does not experience too much burden or, in 
the case of food, deprivation.  Finally, goals are traditionally followed-up on a weekly 
basis and, when appropriate, feedback from other group members and leaders is 
provided to help patients modify current goals or add new goals. 
 Recent studies based on the SCM with a community sample of African American 
women with obesity (Damschroder, Lutes, Goodrich, Gillon, & Lowery, 2010) and a 
sample of veterans with an average 3.8 MCC (Lutes, et al., 2012), showed continued 
behavior change and improvements in health outcomes (i.e. weight loss) up to three 
months after the intervention was complete.  In a third study (N=25), a six month bi-
weekly follow-up program (15 minutes telephone sessions) was added on to the original 
10 week program which resulted in clinically significant weight loss at nine month follow-
up (Lutes et al., 2010).  The SCM has shown to be effective at improving weight loss 
outcomes using individual and group formats in combination with face-to-face, Internet, 
and telephone follow-up methods (Lutes & Steinbaugh, 2010; Lutes et al., 2012).  





community health workers and a culturally tailored adaptation of the SCM treatment with 
African American women with diabetes. 
 For many reasons, the SCM approach is potentially generalizable to medication 
adherence interventions.  One of the major limitations in the medication adherence 
intervention literature is the weak evidence for achieving sustained adherence for 
medications taken over a long period of time.  The SCM aims to create sustainable 
behavior change through its individualized goal-setting approach.  Patients with MCC 
are typically on a unique medication regimen and this flexible approach allows patients 
to use their baseline data to inform the selection of their goals (e.g. one medication or 
aspect of medication taking).  Moreover, encouraging patients to self-select a small goal 
may help increase their perceived control and decrease the overwhelmed feeling that 
many report related to their regimen (McSharry et al., 2012; Townsend et al., 2003).  
Finally, the SCM includes elements used in previous research that has improved 
medication adherence including individualized approaches, addressing patient burden, 
and structured and supportive feedback.  However, the effectiveness of the SCM 
approach for improving medication adherence has yet to be evaluated. 
 Problem-solving for medication adherence.  Because change does not occur 
in a vacuum, interventions should include evidence-based strategies that help 
individuals plan for and overcome psychosocial and economic barriers that impede 
adherence efforts.  In fact, training in effective problem-solving is a recommended 
evidence-based approach for improving self-efficacy and self-management skills in 
patients with chronic conditions (Marks et al., 2005b).  Problem solving training (PST) is 





on by the medical field and focuses on building social competence through enhancing 
problem solving abilities (D’Zurilla & Goldfried, 1971; D’Zurilla & Nezu, 1999).  This 
approach is a self-directed learning process aimed at improving one’s abilities to 
perform necessary tasks in the face of adversity as well as a general coping strategy 
that can be used to minimize the impact of minor and major stressful events.   
 Research shows that PST in isolation or as part of a treatment package is an 
effective method for improving physical and psychosocial outcomes in patients with 
chronic conditions (Cook, 2006; Hill-Briggs, 2003; Glasgow, Fisher, Skaff, Mullan, & 
Toobert, 2007; Lorig et al., 2005; Perri et al., 2001) and limited literacy (Hills-Briggs et 
al., 2011).  The extent and manner that PST is implemented in self-management 
programs varies greatly across studies and settings.  Regardless, PST is commonly 
referred to as a behavioral intervention as many studies provide only problem solving 
skills training.  However, it was designed to address the cognitive and behavioral 
aspects of problem-solving as well as motivational and pragmatic issues (Cook, 2006; 
D’Zurilla & Nezu, 1999). 
 The first element of PST is to create a positive and constructive problem-solving 
orientation by targeting peoples’ negative cognitions or conflicting beliefs about their 
problem solving ability based on past experiences.  The ABC method is an example of 
an orientation strategy (Cook, 2006).  With this approach patients are asked to first 
examine their self-talk by identifying the activating event (A), their beliefs (B), and 
behavioral and emotional consequences (C) and then reconstruct dysfunctional 
thoughts into constructive ones.  After practicing this with the group in session, patients 





second and more commonly used behavioral element is aimed at improving one’s 
problem-solving skills through a five step goal-directed process.  Notably, a review of 
diabetes self-management interventions reported that interventions that included 
training in both the cognitive, problem-orientation training, and the behavioral, problem-
solving skills, elements have stronger effect sizes than those that only provide 
behavioral skills training (Malouff et al., 2005).  According to D’Zurrila and Nezu (1999) 
the cognitive element is closely related to the theoretical constructs of perceived control, 
self-efficacy, and Lazarus’s stress appraisal model (Bandura, 1997; Lazarus & Folkman, 
1984).  Improvements in problem-solving orientation may be particularly beneficial for 
those who report distress related to their medication regimen, a common concern for 
patients with MCC.  Developing interventions that include both the cognitive component 
and behavioral component of PST may enhance the effectiveness.   
 Research shows that health outcomes are more likely to improve when problem-
solving skills are shaped, revisited, and reinforced throughout the intervention (Glasgow 
et al., 2007, Malouff et al., 2005; Lorig et al., 2005).  For example, homework might 
consist of practicing adopting a positive orientation and using problem-solving skills in a 
problematic situation.  Additionally, a portion of the following program session should be 
dedicated to reviewing efforts, receiving feedback, and setting new problem-solving 
goals.  Therefore, with experience in overcoming expected (e.g. medication 
adjustments) or unexpected (i.e. falling ill) problems that interfere with medication 
adherence efforts, confidence to overcome barriers improves.  However, there is a 
paucity of research available evaluating the effectiveness of PST as a mechanism for 





In sum, based on previous research on interventions for medication adherence, 
there are a few approaches that have helped patients improve their adherence and 
even fewer that report sustained improvements.  Review of the literature suggest that 
the most successful interventions have used a combination of educational and 
behavioral strategies.  Research from the self-management literature suggests that 
interventions involving education and training and feedback on cognitive and behavioral 
skills can promote improvements in self-efficacy and medication adherence for patients 
with MCC.  Each strategy presented here is grounded on social cognitive theory and 
evidence based cognitive behavioral approaches.  Each allows for individualization 
based on patient needs which will likely be a valuable element in future interventions for 
patients with complex health conditions.  Finally, these approaches are strengthened by 
the fact that each strategy can be generalized to other self-management tasks, but also 
target measurable outcome (e.g. medication adherence).   
Adapting cognitive and behavioral interventions for limited health literacy 
populations.  When providing cognitive and behavioral skills training for individuals with 
limited health literacy, a number of considerations must be taken into account.  For 
many cognitive and behavioral interventions, the program only briefly reviews the 
educational material patients are expected to read and quickly moves into implementing 
behavior change strategies.  As previously discussed, individuals with limited health 
literacy would benefit from programs that provide tailored information and basic 
education on critical aspects of adhering to a medication regimen prior to asking 
individuals to make changes.  Another consideration is ensuring that each intervention 





using the “teach back” method to confirm comprehension, incorporating interactive 
exercises with case examples that are common in the population (Kuhajda, Thorn, 
Gaskins, Day, Cabbil, 2011), focusing on select critical strategies (Rothman et al., 
2009), and providing feedback on patient success in implementing behavior change 
strategies.   
The cognitive and behavioral strategies discussed above can also be adapted for 
individuals with limited health literacy.  A portion of the initial session may be dedicated 
to the rationale and process of self-monitoring and training in self-monitoring may 
include walking patients through how to complete a self-monitoring log.  The SCM’s 
philosophy is useful for patients with limited literacy as the goal setting criteria are 
concrete and specific to critical behaviors.  However, setting the first goal is typically 
couched within the session that covers many educational topics and strategies for 
categorizing food intake.  Adaptations for limited health literacy may instead dedicate 
most of one session to education on “small goals” that includes a case example 
followed by an interactive exercise for creating one’s first goal.  Finally, PST handouts 
are typically written at an advanced reading level using psychological jargon.  Similarly, 
PST incorporates many problem-solving orientation and skills training strategies into its 
approach.  This approach may be adapted for limited health literacy populations by 
removing jargon and selectively choosing strategies (i.e. ABC method, “teach back” 
problem-solving skills) that are appropriate for improving medication adherence in 
limited literacy population.   
Providing Evidence-based Interventions in FQHCs 





most FQHCs have limited resources for meeting the unique needs of this patient 
population for two primary reasons First, providers have limited interaction per visit per 
patient due to the number of patients seen in a primary care clinic (Boyd & Fortin, 
2010).  This makes it difficult to address barriers that can interfere with adherence, such 
as access to services and behavior change strategies.  Second, although patient 
education about disease management is a standard of practice, it is often disease 
specific and accomplished using informational pamphlets and lists of resources 
(Bodenheimer et al., 2002).  These methods for providing self-management education 
or treatment regimen recommendations are not adequate for many patients, particularly 
for those with MCC and/or limited health literacy.   
A recent goal of the Bureau of Primary Health Care  (Parekh & Goodman, 2013) 
and its partners include reducing health disparities in FQHC populations by improving 
self-management services.  Self-management programs situated in the primary care 
setting can alleviate some of the burden faced by providers and nursing staff 
(Bodenheimer et al., 2002).  The primary care provider can be easily informed and 
consulted regarding the patient’s status and progress.  Also, the program can meet the 
biopsychosocial needs of patients with MCC by meeting them at the point of care, 
providing assistance in medication adherence, and connecting them with other 
community or clinic services.  Moreover, given the common co-occurrence of mental 
health problems with chronic diseases, programs can provide an additional venue to 
assess, monitor, and, if needed, refer patients for behavioral health or specialty mental 
health treatment.   





state, and foundation grants, but they are not sustainable beyond the period of initial 
funding.  The inability to sustain these programs is likely due to a combination of factors, 
including ongoing financial constraints, poor collaboration or integration between 
agencies, interventionist turnover, or reallocation of resources.  Thus, engaging 
individuals involved in direct patient care in identifying the self-management needs of 
the patient population and collaborating with clinic administrators on the implementation 
of self-management programs may enhance sustainability (Beacham, Herbst, 
Streitwiser, Scheu, & Sieber, 2012; Daniels, Campbell, & Dixon, 2014; Glasgow, 
Klesges, Dzewaltowski, Bull, & Estabrooks, 2006).   
The current research and literature suggests that patients with MCC have 
multiple needs related to self-management and that these needs may vary based on 
sociodemographic factors and the clinical setting.  Subsequently, this review stimulated 
questions regarding the self-management needs of an understudied population in 
Eastern North Carolina.  Therefore, we completed a two-part pilot study.  The first part 
involved a survey aimed at engaging patients and providers of a local FQHC in the 
research and program development process.  The second part used the results of the 
pilot study to inform development and evaluation of an intervention aimed at improving 
patient self-management of MCC.
Study 1: Pilot Survey Study of Chronic Disease Self-Management Needs 
The objective of the survey was to solicit perspectives from both patients and 
providers about the self-management needs of patients with chronic conditions.  There 
were three specific aims for this exploratory survey study. 





patients in a rural clinic with limited resources. 
• AIM II: Explore perceptions of chronic disease self-management needs among 
patients and providers.   
• AIM III: Evaluate whether the needs of patients with MCC are different than 
patients without MCC.  
Study 2: Medication Adherence Intervention StudyBuilding on the pilot study and 
limitations in current research, the current project involved the development and 
implementation of a health literacy-adapted medication adherence program for patients 
with MCC.  The priority population from which the study sample will be drawn is largely 
understudied. 
 The content of the program is grounded in theory and informed by chronic 
disease research on interventions for medication adherence and self-management.  
Therefore, the intervention specifically focuses on strategies drawn from SCT, CBT, 
SCM, and PST.  The intervention targets improving self-efficacy with emphasis on 
improving health literacy related to medication adherence in the initial sessions and 
emphasis on behavior change for improving medication adherence in latter sessions.  
Based on the results of the pilot study, program topics on barriers to medication 
adherence includes problem-solving and coping with stress-related to daily 
responsibilities and medication-related distress.   
Specific aims and hypotheses of the proposed project:  
• AIM 1: Obtain descriptive data of an understudied sample of patients with MCC 
including demographic data, number of chronic conditions, and measures of 





• AIM II: Examine the relationships between number of chronic conditions and 
primary outcome (medication adherence) and secondary outcome variables 
(problem-solving skills, self-efficacy, and QOL) at baseline. 
o Hypothesis 1: There will be a significant negative correlation between 
number of chronic conditions and primary (medication adherence) and 
secondary outcomes (health literacy, problem-solving, self-efficacy, and 
QOL).   
o Hypothesis 2: There will be significant positive correlations between 
medication adherence, health literacy, self-efficacy, problem-solving, and 
QOL. 
• AIM III: evaluate the preliminary efficacy of an intervention for patients with MCC 
on primary (medication adherence) and secondary (health literacy, self-efficacy, 
problem-solving, and QOL) outcomes. 
o Hypothesis 1: Compared to baseline assessment, medication adherence, 
self-efficacy, problem-solving skills, and QOL will be significantly greater at 
post-treatment assessment. 
o Hypothesis 2: Change in self-efficacy scores from baseline assessment to 
post-treatment assessment will predict medication adherence. 
Chapter III: Methods 
Study Site 
The site of both studies was Kinston Community Health Center (KCHC), a rural 
Federally Qualified Health Center (FQHC) in Lenoir County, North Carolina.   According 
to the 2013 Robert Wood Johnson survey of health outcomes in North Carolina, Lenoir 
County is ranked 94th out of 100 North Carolina counties for health outcomes as 
measured by morbidity and mortality and 77th for health factors related to behavioral 
and social characteristics (e.g. health behaviors, access to and quality of care, 
socioeconomic factors).  KCHC provides health care services to underserved residents 
who as a whole are often undereducated and underemployed.  Also, most patients at 
KCHC are African American (48%) or Hispanic/Latino (27%) and are uninsured with 
only approximately 27-32% having some type of insurance, primarily Medicaid and 
Medicare.  Together these statistics underscore the substantial health disparities 
experienced in this region and need for tailored self-management programs. 
In an effort to reduce health disparities in this region there have been ongoing 
collaborations with KCHC in recent years.  From 2010 to 2013 we conducted a diabetes 
self-management program.  We have also completed a case study evaluating 
implementation of a depression screening protocol and enhancement of behavioral 
health care at KCHC.  Subsequently, collaborative relationships have developed with 
individuals at each level of service from the front desk and administrative staff to the 
medical and behavioral health providers.  Moreover, successive Chief Executive 
Officers and other executive officers continue to be receptive to future self-management 




planning of this project.  These relationships have led to a gradual increase in referrals 
to the diabetes self-management program as well as provided exposure of clinical 
research methods to providers and staff and opportunities for this student researcher to 
gain additional experience in conducting research in a medical setting.  
Institutional Review Board (IRB) Approval.  
All research procedures including data collection and storage, recruitment, 
survey administration, and intervention materials and procedures were approved by the 
East Carolina University IRB prior to study implementation (See Appendix A for study 
approvals for the Survey study: UMCIRB-12-001914 and Intervention study: UMCIRB-
13-001992). 
Chapter IV: Study 1  
The pilot study aimed to survey the perspectives from both patients and 
providers about the self-management needs of patients with chronic conditions.  The 
methods and data analysis and brief discussion specific to the pilot study are presented 
below.
Method 
Participants. Individuals were eligible to participate in the survey if they were at 
least 18 years or older and presenting for care at the FQHC.  Individuals were excluded 
from the survey if they were under the age of 18, non-English speaking, or were not 
currently patients of the FQHC.  Additionally providers in the family medicine and 
behavioral health departments were eligible to participate in the survey.   
Materials. The patient and provider surveys were developed for this study.  The 
patient survey was designed to be brief and written for individuals with limited primary 
literacy and limited health literacy.  Both patient and provider surveys addressed 
important domains of care for chronic conditions: chronic disease self-management 
tasks, patient-provider communication, psychosocial barriers of self-management, and 
preferences related to a chronic disease self-management program under development 
at the clinic.  Provider and patient versions of the surveys are located in Appendix B. 
Procedure. Adult patients were approached in the waiting room and asked if 
they would be interested in completing an anonymous survey about their health care.  
Verbal consent was obtained from all patients prior to completing the survey.  The 
research assistant verified literacy levels by asking participants if they felt comfortable 





Descriptive statistical analyses were used to identify the prevalence of chronic 
conditions, and frequency of specific chronic conditions,  as well as the frequency with 
which patients and providers endorsed survey items.  Pearson Chi-square test was 
employed to evaluate differences in frequencies between groups. 
Results 
Sample characteristics.  A total of 53 patients agreed to complete the survey.  
All providers (n = 14) agreed to complete the survey.  The majority of patients had 2 or 
more chronic conditions (62%) and 45% of patients reportedly had three or more 
chronic conditions.  Hypertension was the most prevalent chronic disease reported by 
79% of the sample, followed by diabetes (34%), arthritis (26%), high cholesterol (26%), 
sleep problems (25%), depression/anxiety (23%), chronic pain (21%), asthma (17%), 
obesity (8%), heart disease (7%), and borderline diabetes (2%).   
Group characteristics.  Table 2 lists the most frequently identified self-
management needs and barriers across each domain by patient and provider group.  
Weight management and medication adherence were among the top identified self-
management improvement needs by patients (49%, 42%, respectively) and providers 
(86%, 64%, respectively).  Patients and providers ranked overcoming stress related to 
daily responsibilities, emotional distress, and health-related distress as the top three 
(out of six) psychosocial barriers to self-management.  Both patients (88%) and 
providers (93%) overwhelmingly endorsed updates to providers regarding patient 






Chronic disease self-management needs by patient and provider 
Patient endorsement n = 53 Provider endorsement n = 14 
Self-management tasks  Self-management tasks  
Making lifestyle changes 49% Weight management/loss 86% 
Weight management/loss 49% Medication adherence 64% 
Medication adherence 42% Patient-provider communication 43% 
Patient-provider communication  Patient-provider communication  
Health care goal-setting/decision-
making 35% 
Communicate challenges in 
keeping appointments 64% 
Communicate symptom side-
effects, symptom changes 29% 
Health care goal-setting/decision-
making 57% 
Psychosocial barriers   Psychosocial barriers   
Stress related to daily 
responsibilities 40% 
Stress related to daily 
responsibilities 64% 
Emotional distress 34% Emotional distress 50% 
Health distress 32% Health distress 43% 





Patient updates provider 54% Update in health record 71% 
Update in health record 46% Patient updates provider 21% 
 
Group differences.  Pearson Chi-square test and Fisher’s Exact test were used 
to identify differences between groups.  Providers were significantly more likely (64%) 
than were patients (17%) to indicate that patients would benefit from improving 
communication about keeping appointments !2(1, N = 65) = 8.34, p = 0.008, OR = 2.67.  
Patients were significantly more likely (44%) than providers (21%) to prefer the face-to-
face communication !2(1, N = 62) = 4.67, p = 0.031. 
Differences between patient groups based on the number of chronic conditions 
self-reported by patients were also examined.  Notably, 38% of patients with 3 or more 
chronic conditions endorsed a desire to improve self-management of MCC while there 
was no endorsement among patients with less than 3 chronic conditions, !2(1, N = 53) = 




significantly more likely (44%) to endorse needing improvement in pain management 
compared to patients with less than 3 chronic conditions (17%), !2 (1, N = 53) = 6.47, p 
= 0.011, OR = 2.94.  Patients with 3 or more chronic conditions were twice as likely 
(54%) as patients with less than 3 chronic conditions (27%) to report that stress related 
to daily responsibilities interfered with self-management efforts, !2 (1, N = 53) = 3.86, p 
= 0.049, OR = 2.75. Patients with two or more chronic conditions (45%) also were 
significantly more likely to endorsed stress related to daily responsibilities compared to 
patients with less than two chronic conditions (23%), !2 (1, N = 50) = 5.56, p = 0.018, 
OR = 2.65.
Implications for Intervention Priorities 
Sixty percent of patients surveyed in this clinic reported having MCC, which is 
more than double the national estimate indicating that 25% of patients in primary care 
have MCC (Boyd & Fortin, 2010).  Collectively, providers and patients endorsed similar 
self-management needs and psychosocial barriers.  Both groups agreed that weight 
management and medication adherence scales were the most important self-
management needs; however, providers more frequently endorsed these topics as 
important.  Specifically, weight management was ranked by 86% of providers versus 
49% of patients and medication adherence was ranked by 64% of providers versus 46% 
of patients.  This suggests that providers collectively agree on which self-management 
needs are the highest priority, but their patients may have less insight into the relative 
importance of these areas.  Both groups similarly ranked managing stress related to 
daily responsibilities, emotions, and health-related distress as the greatest barriers to 




improvement in communication about health-care decision making and goal setting 
were also among the highest ranked communication needs by all participants. 
Weight management and medication adherence were the top identified self-
management improvement needs by patients and providers, which is consistent with 
priorities in the public health domain.  For many reasons it is more appropriate to 
intervene on medication adherence before focusing on other lifestyle changes, including 
weight management.  First, achieving medication adherence is the single most 
important modifiable aspect of managing MCC because it provides an immediate health 
risk reduction (Sabate, 2003).  Second, providing a medication adherence intervention 
at the point of care where medications are primarily managed creates unique and 
convenient opportunities to facilitate patient-providers communication (another critical 
aspect associated with better health outcomes in patients with MCC).  Third, lifestyle 
change interventions focus on changing multiple health behaviors, but it may be more 
appropriate to focus on one type of behavior change (i.e. medication adherence) with 
the priority population.  Patients in this population are more likely to have limited health 
literacy and little, if any, experience in self-management programs.  Therefore, focusing 
on a single measurable behavior decreases the cognitive load and creates extra time 
for exposure to and honing of behavior change skills.  These skills can be subsequently 
generalized to address more complex lifestyle changes, like weight loss.  Fourth, all 
patients with MCC are on a medication regimen, yet not all patients with MCC are 
overweight or obese.  Fifth, research from the literature indicates that, for patients with 
MCC, the medication regimen is the most challenging and distress aspect of managing 




intervention that focuses on medication adherence for patients with MCC.
Chapter V: Methods for Study 2 
The intervention study aimed to evaluate the relationship among variables and 
effects of the intervention on primary and secondary outcome variables in a sample of 
patients with MCC.  The methods and data analysis specific to the intervention study 
are presented below.  
Method 
Participants. Participants were patients of the Kinston Community Health 
Center.  Eligibility criteria included: 1) at least 18 years or older and 2) diagnosed with 
two or more chronic diseases.  Patients were excluded from the study if they were 
under the age of 18, non-English speaking, below sixth grade reading level, diagnosed 
with cognitive impairment, reported suicidality or psychotic symptoms, or appeared to 
be a better fit for one-on-one intervention.  If patients were eligible but did not have 
medication access through insurance or were not yet enrolled in the clinic’s medication 
assistance program, they were referred to the program coordinator to get enrolled which 
served to further integrate the program into the clinic setting.  Enrollment in the 
medication assistance program was not an eligibility requirement for the study.   
Recruitment. Research with members of minority groups living in rural 
communities suggests that additional strategies are necessary to enhance recruitment 
and retention (Burns, Skoward, Skelly, Leemon, & Carlson, 2008).  Therefore the 
researchers worked closely with individuals within the clinic before, during, and after the 
planning and implementation of the research project and the intervention materials were 
tailored to meet the needs of the populations and to be culturally congruent.  Also 




patients could self-refer by calling the number listed.  Providers were also a source of 
recruitment and were notified of the study and participant eligibility criteria.  Providers 
could directly refer the patients to the program recruiter or provide informational 
handouts to patients whom might benefit from the program.  If patients expressed 
interest in the program, they were invited to complete an enrollment session that day or 
scheduled for a future date, which included informed consent, an introduction to 
program materials, and a baseline assessment of psychosocial health outcomes.  
The consent form was written at a sixth grade reading level, which was 
determined using sentence by sentence analysis with Microsoft Word’s Readability 
Statistics program.  This document was read to the patient and time was provided for 
the patient to ask questions about the experience of being a research participant and 
participating in the intervention. Each participant was provided a copy of the consent 
form to take home. 
Intervention mode and duration. The program utilized a closed-group format 
with 4-7 group members in each group.  There were seven contacts made with the 
participants.  The first contact was at enrollment (1.5 hr session), which consisted of 
informed consent, introduction to group materials, and baseline assessment.  Group 
sessions were held weekly for 4 weeks (1.5 hr each).  Follow-up included 2 weekly 
individual telephone sessions (30 min each).  Post-treatment assessment occurred with-
in one week of last phone contact (Figure 3). 
Intervention materials.  Participants received a packet of program materials 
throughout the program.  The packet contained educational handouts and worksheets, 




The intervention materials were adapted for limited primary literacy and limited health 
literacy populations using the Checklist of Key Principles of Effective Low-Literacy Print 
Materials developed by the NCI (2003).  Individualized dosing schedules were compiled 
from the results of the baseline assessments, medical record chart review, and 
designed so participants can log and monitor outcome changes over time.  Participants 
completed the self-monitoring logs over the course of the program for the purpose of 
tracking weekly self-selected goals and medication taking behaviors.   
Group session format.  A detailed session-by-session outline is available in 
Appendix C and a brief overview of the session content is available in Table 3.  Core 
skills and interventions were adapted from the SCM (Lutes & Steinbaugh, 2010) and 
PST (D’Zurilla & Nezu, 2009; Cook, 2009) to enhance medication adherence.   
Although specific content varied across sessions, each session followed the 
same agenda including: agenda setting, check-in, topic introduction, group discussion, 
didactics, skills training and practice, goal-setting, and feedback.  At the start of each 
session, participants were welcomed back to group and the agenda was announced.  
The group proceeded into an initial check-in on how the participant’s weeks went and 
brief impressions of goal achievement efforts.  Next, the new topic and skill was 
introduced and there was a time for the group members to discuss and reflect on their 
experiences with that topic (e.g. thoughts and feelings about topic, personal barriers, 
successes at coping, etc.).  Following this discussion the group leader provided 
psychoeducation on the medication adherence topic and engaged participants in an 




to setting goals, which included developing personalized action plans.  During this time 
leaders reinforced successes and provided feedback.   
 
Table 3  
Overview of Session Content 
 Primary Objective(s) Education  Skills Training  
Session 1 • Enhance motivation 
for improving 
medication adherence 
• Build cohesion 
• Program 
philosophy 
• Group rules and 
process 
• Self-monitoring  
• Goal-setting 
• Self-monitoring  
• Goal-setting 
Session 2 • Reinforce self-
monitoring and goal-
setting skills 
• Improve health literacy 
• Medication 
prescriptions 




• Create a dosing 
schedule 
• Use a pill 
organizer 
Session 3 • Reinforce goal-setting 
skills 









• Goal-setting  
• The ABC 
Method 
Session 4 • Reinforce goal-setting 
skills 












• Reinforce goal-setting 
skills 
• Reinforce problem-
solving orientation and 
skills 
•  None • Feedback on 
goal-setting and 
problem-solving 






Individualized booster telephone sessions.  Booster sessions were intended 
to provide individualized follow-up, reinforcement, and feedback on participants’ 
problem-solving skills for medication adherence.  Conversations followed a similar 
agenda to group sessions, with the exception of introducing a new topic, instead, 
previously learned skills were revisited as needed.  During this session, the leader 
provided specific recommendations in order to facilitate problem-solving and solution 
identification.  At the end the leader and participant created an action plan and 
scheduled the next phone session. 
Participant compensation.  Participants were informed during enrollment that 
they would receive compensation for enrolling and completing the program and follow-
up assessment.  They received $30 in gas cards to offset any transportation costs 
accrued while commuting to the clinic for program sessions and assessments.  
Participants received one $15 gas card at enrollment and one $15 gas card after post 
treatment data were collected.  Participants who did not have or could not arrange for 
transportation were provided transportation via the clinic’s outreach service van.  
Participants who utilized the clinic’s transport van did not receive the gas card. 
 Referral procedure and collaboration.  In an effort to provide collaborative 
patient-centered care, the medical providers and behavioral health provider at KCHC 
were contacted throughout the project regarding their patients.  Two scenarios have 
been identified for when contacting providers would be appropriate.  One scenario was 
in the event that the participant exhibits or reports substantial distress, suicidal thoughts, 
or concerning medical symptoms.  The medical provider was contacted immediately 




the on-site walk-in clinic for treatment.  Additionally, the behavioral health provider, a 
licensed psychologist, was involved in planning program implementation and available 
on site as needed for consult and referrals.  The other scenario was to facilitate 
coordinated care on behalf of the participant.  Per the results of the patient and provider 
survey, the program leader updated providers on participant progress.  During the 
informed consent process these procedures were reviewed and the group leader 
explained methods of disclosure with the participant.  The participants were asked if 
they would like the program leader to update their provider on their progress over the 
course of the intervention.  All participants were given the option to opt out of provider 
updates. 
 
























Assessment of Primary and Secondary Outcomes 
Medication adherence.  Medication adherence in patients with MCC, the primary 
outcome in the present study, is most commonly assessed using self-report measures 
and daily self-monitoring logs.  Morisky and colleagues (2008) developed and validated 
an eight-item Morisky Medication Adherence Scale (MMAS) based on the theory that 
medication adherence is influenced by a number of factors including psychosocial 
barriers and regimen complexity.  The MMAS was validated in a large study (N = 1367)  
(Morisky et al., 2008).  It was determined to have good reliability (alpha = 0.83) and to 
be a valid predictor of health outcomes (e.g. blood pressure control).  Cut points were 
chosen based on the scale’s relationship with blood pressure control, such that patients 
with well-controlled blood pressure earn higher scores.  On the MMAS, high adherence 
correlates with a score of 0, medium adherence with scores of 1 or 2, and low 
adherence with scores greater than 2.  Regarding missing data, the authors of the 
MMAS utilize the completion criteria of 75% in order for a questionnaire to be 
considered valid.  Reliability for the scale with the current sample fell just short of 
acceptable with internal-consistency of ! = .69. 
Patients were also asked to complete a daily medication self-monitoring log of up 
to three medications.  The log was designed to match the patient’s unique dosing 
schedule, and patients simply checked off when they took their medication.  Baseline 
medication adherence was determined by the first week of self-monitoring, and patients 
were asked to make no changes to their current patterns.  The log had a space for the 
patient to add the number of times they were supposed to take their medications and 




Health literacy.  Although there is no gold standard for assessing health literacy, 
research suggests that the Test of Functional Health Literacy in Adults short form (S-
TOFLHA) to be the most reliable and valid measure of functional health literacy (Baker, 
Williams, Paker, Gazmararian, Nurss, 1998; von Wagner et al., 2009).  Reliability and 
validity studies demonstrated that the STOFHLA has strong internal consistency (alpha 
= 0.97) and that it is highly correlated with other measures of health literacy including 
the Rapid Estimate of Adult Literacy in Medicine (Davis, Crouch, & Long, 1992) and the 
full TOFHLA, with r = 0.81 and 0.91, respectively.   
The STOFHLA is a 36-item timed test (maximum time = 7 minutes) that uses 2 
reading passages from the original extended version of the assessment.  The 
STOFHLA assess reading comprehension via two passages about different healthcare 
scenarios; one is written at 4.3 grade reading level and the other is written at a 10.4 
grade reading level.  In each passage, words are omitted and the participant is asked to 
select the omitted word from four multiple-choice options.  A total score between 0-16 
indicates inadequate health literacy, a score between 17-22 indicates marginal health 
literacy, and a score between 23-36 indicates adequate health literacy.  Reliability for 
the scale with the current sample was good with internal-consistency of ! = .969. 
Health-related problem solving.  The Health-related Problem Solving Scale 
(HPSS; Hill-Briggs, Gennell, Kukarni, Klick, Brancati, 2007) is designed based on 
problem solving theory (D’Zurilla & Nezu, 1999) and chronic disease self-management 
model (Hill-Briggs, 2003).  The scale has 50 items with 5-point Likert style response 
option format and can be completed in 5-10 minutes.  Questions are derived from a 




effectiveness (i.e. change in abilities over time; Hill-Briggs, Cooper, Loman, Brancati, 
Cooper, 2003).  The scale has seven subscales that relate to the 7 domains of problem-
solving theory: effective problem solving, impulsive problem solving, avoidant problem 
solving, positive learning, negative learning, positive orientation/motivation, and 
negative orientation/motivation (Hill-Briggs et al., 2007).  Higher scores on the 
subscales indicate more of that problem-solving characteristic and higher HPSS total 
score indicate better problem-solving.  In the validation study of the HPSS (Hill-Briggs et 
al., 2007), average Total HPSS score was 19.7 (SD = 4.0) and mean HbA1c was 
significantly greater in participants scoring below 18.5 compared to those with scores 
greater than 21.9.  Cronbach’s alphas were 0.86 and 0.89 for diabetes and HIV minority 
populations, respectively, and positive subscales were weakly correlated with their 
corresponding negative subscales.  Further, the HPSS total score and subscale scores 
strongly and significantly correlate with health outcomes (e.g. HbA1c, hospitalizations, 
ED visits).  This will be the first study using the HPSS to evaluate problem-solving in a 
multimorbidity sample.  Reliability for the HPSS scale with the current sample was good 
with internal-consistency of ! = .924. 
Health-related quality of life.  The World Health Organization developed a 
quality of life measure for health care populations that is available in the public domain.  
The World Health Organization Quality of Life – BREF scale (WHO QOL-BREF) is a 
brief measure of quality of life with only 26 items compared to the original 100 item 
measure (Murphy, Herrman, Hawthorne, Pinzone, Evert, 2000).  The scale assesses 
general quality of life with two questions and four domains (physical, psychological, 




scores are transformed into scaled scores (0-100) with higher scores indicating higher 
quality of life.  Cronbach’s alphas for the four domains were as follows physical health = 
.86, psychological = .76, social relationships .66, and environment = .80 and test-retest 
reliabilities across domains ranged from .66 to .87.  The scale is highly correlated with 
single item measures of general quality of life and all four scales significantly 
differentiate between healthy and chronically ill populations.  Cases were deleted if 20% 
of the participant’s data was missing.  Reliability for the scale with the current sample 
was good with internal-consistency of ! = .831. 
Self-Efficacy.  The Chronic Disease Self-efficacy Scale (CDSES, Lorig et al., 
1996) assesses patients’ self-efficacy for managing their chronic conditions and 
developed out of Bandura’s self-efficacy theory (1986).  The 32-item scale with 10-point 
Likert style response options assessing three categories of self-efficacy beliefs and 
confidence: to perform specific behaviors (e.g. exercise regularly, communicate with 
physician and family, obtain information about disease), to manage disease generally 
(e.g. manage condition on regular basis, engage in regimen tasks and reduce disease-
specific distress), and to achieve outcomes (e.g. engage in chores and pleasurable 
activities, manage symptoms and depression, etc).  Scores are calculated by obtaining 
the mean in each category and scores closer to 10 indicate higher self-efficacy.  
Reliability for the CDSES with the current sample was good with internal-consistency of 
! = .961. 
The Medication Adherence Self-efficacy Scale (MASES, Ogedegbe, Mancuso, 
Allegrante, & Charleston, 2003) assesses patients’ perceived self-efficacy for taking 




confidence in their ability to take medications all of the time across various situations.  
Response options include not at all sure, somewhat sure, very sure and are scored 1, 2, 
or 3, respectively.  Psychometric research (Ogedegbe, et al., 2003) involving patients 
with hypertension indicated that that the MASES is internally consistent with a reliability 
coefficient r = 0.95.  Additionally, patients with controlled blood pressure generally 
scored higher (M = 2.54) compared to patients with uncontrolled blood pressure (M = 
2.48).  Although group differences were not statistically significant, these scores were in 
the predicted direction and provided preliminary evidence for an inverse relationship 
between self-efficacy and blood pressure.  Reliability for the MASES with the current 






Overview of Study Outcomes by Measures 
Outcomes Assessment Measure Description 
Primary Outcome   
Medication adherence MMAS (8 items) Self-report measure of 
medication self-
management  
   
 Daily self-monitoring log Percentage of medication 
taken divided by 
prescribed 
recommendations 
Secondary Outcomes   
Health Literacy STOFLHA (36 items) A brief assessment of 
health literacy using 
health-related items 
Health-related quality of 
life 
QOL (26 items) Brief self-report of quality 
of life specific to 
populations with chronic 
conditions 
Problem-solving HPSS (50 items) Self-report of ability to 
overcome barriers to self-
management and cope. 
Self-efficacy CDSES (32 items) Self-report of perceived 
self-efficacy for health 
care self-management  
 MASES (26 items) Self-report of confidence 
for taking medications 
across situations 
Note: CDSES Chronic Disease Self-efficacy Scale (CDSES) Health-related Problem Solving Scale, 
(HPSS), Medication Adherence Self-efficacy Scale (MASES), Morisky Medication Adherence Scale 
(MMAS), Test of Functional Health Literacy in Adults – short form (STOFLHA), World Health Organization 








A power analysis was completed using the statistical software, G*power version 
3 (Buchner, Erdfelder, & Faul, 1997).  Although the average effect size (d) for 
educational and behavioral interventions for medication adherence is 0.54, significant 
heterogeneity among studies makes it difficult to draw definitive conclusions regarding 
the effectiveness of current interventions (Kripalani et al., 2007).  Therefore, a 
conservative and small effect size of 0.3 was chosen based on the limited available 
evidence for studies involving similar populations that also utilize the proposed dose 
and mode of treatment and integration of strategies.  Based on two-samples repeated 
measures t-test, a sample size of 55 is needed to have at least 80% power and 
traditional .05 criterion of statistical significance.  
 Attrition analyses for studies of medication adherence interventions (educational 
+ behavioral components) for patients with MCC report retention ranging from 82% to 
100%.  However, characteristics that are common in this population (i.e. limited 
transportation and economic resources, distrust of researchers, and lack of 
infrastructure for research) are known barriers for completing programs and increasing 
attrition (Loftin, Barnett, Bunn, & Sullivan, 2005).  Retention for another chronic disease 
intervention study recently completed at KCHC was 16 out of 39 patients or 41%.  As 
previously discussed, the lab has established a collaborative relationship with KCHC 
and employed strategies that enhance recruitment and retention.  Therefore a 
conservative projected attrition estimate of 50% was used and the proposed project 
attempted to enroll 64 patients.
Chapter VI: Results for Study 2 
Participant Attrition  
In an effort to provide information regarding recruitment and retention in rural 
primary care research, Figure 4 depicts participant flow from referral to post-treatment 
assessment.   The most effective method of recruitment was through direct provider 
referral which produced 118 out of 119 referrals.  Referred patients were contacted by 
telephone or upon arrival at the clinic for their medical appointment.  At this time, the 
program coordinator briefly provided information about the program and answered any 
questions; those who expressed interest (n = 54) scheduled an interest 
meeting/appointment with the program coordinator.  Despite reminder calls, twenty-five 
patients never attended their scheduled appointment and some were rescheduled up to 
three times.  The program coordinator discontinued contact after the third missed 
appointment.   
Of the 29 patients who attended the interest meeting, 20 completed the informed 
consent process including baseline assessment and were assigned to a group.  
Reasons for not enrolling include ineligibility (n = 7) and disinterest (n = 2).  The first 
group meeting was scheduled after at least four participants were assigned to a group.  
Therefore, the delay between the interest meeting and first group meeting ranged from 
two to five weeks.  There was some attrition during this delay as contact was lost with 
one individual, one obtained a job, and two became “too busy.” Therefore, 16 
participants began the group intervention and 13 participants completed.  Overall, 
attrition from the baseline assessment was 35%.  However, once participants attended 




With regard to attendance throughout the intervention, completers received 79% 
of the intervention contacts.  Attendance rates throughout the intervention were high as 
completers attended 85% of the group sessions (44 out of 52) and 77% of the 
telephone sessions (20 out of 26). Two of the missed group meeting were completed 































Sociodemographic characteristics. Univariate statistical analyses were 
completed to determine the socio-demographic characteristics of the sample (N = 20, 
Table 5).  The sample was evenly balanced by sex (50% male), on average 56 years 
old, and predominantly Black (95%).  Participants were predominantly unemployed or 
disabled (85%), reported an annual income of less than $10,500 (75%).  Sixty-two 
percent of participants reported having at least a high school education and 60% had 
average health literacy as measured by the STOFHLA.  Additionally, participants were 
managing, on average, five chronic conditions and prescribed seven long-term 
medications.  Ninety-five percent (n = 19) of the sample reported receiving medication 
assistance through Medicare/Medicaid (40%), private insurance (15%), or the clinic’s 
PAP (40%).   
Descriptive analyses were completed for the primary variable, medication 
adherence, and secondary variables, health literacy, self-efficacy, problem-solving, and 
QOL.  Table 5 presents the baseline characteristics of the original sample of 20 
participants.   
Table 5 
Participant Baseline Demographic and Psychosocial Characteristics 
(N = 20) 
Demographic Mean (SD), % 
Age (yr) 56.75(8.67) 
Chronic Conditions  5.40 (2.28) 
Medications 7.00 (3.28) 
Sex (% Male) 50% 
Race (% Black) 95% 





Less than High School 





























Psychosocial Measures  
MMAS 4.65 (2.37) 






















































Note: CDSES Chronic Disease Self-efficacy Scale (CDSES) Health-
related Problem Solving Scale, (HPSS), Medication Adherence Self-
efficacy Scale (MASES), Morisky Medication Adherence Scale 
(MMAS), Test of Functional Health Literacy in Adults – short form 
(STOFLHA), World Health Organization Quality of Life scale (QOL) 
 
 Association between demographics and psychosocial variables. Correlation 
analyses and t-tests were employed to determine whether demographic characteristics 
were associated with the primary and secondary psychosocial variables.  Results 
indicated that self-efficacy for self-management of chronic disease symptoms and QOL 
for physical health was statistically significantly associated with increases with age (r = 
.455, p = .044; r = .447, p = .048, respectively).  Also, number of medications was 
statistically significantly correlated with number of chronic conditions (r = .496, p = .031, 
STOFHLA (r = .673, p = .003), MASES (r = .552, p = .014), CDSES do chores (r = -
.447, p = .048).  This indicates that participants with higher number of chronic conditions 
also reported a greater number of medications.  Also participants prescribed a greater 
number of medications also reported higher self-efficacy for adhering to their medication 
regimen and higher scores on the health literacy.  However, as medication prescriptions 
increased, participants report poorer self-efficacy for doing everyday chores.  Group 
analyses indicated that at baseline self-reported medication adherence women had 
statistically significantly better scores (M = 4.90, SD = 2.96) compared to men (M = 




Association between MCC and psychosocial variables.  Correlational 
analyses were employed to estimate the magnitude of associations between the 
number of chronic conditions and baseline measures of medication adherence, health 
literacy, self-efficacy, problem-solving skills, and QOL (Table 6).  Generally, there were 
no significant associations among the variables, with the exception of a statistically 
significant positive correlation with the STOFHLA (r = 0.528, p = 0.036).  This indicates 
that as the number of chronic conditions increased so did scores on the health literacy 
assessment. 
Table 6 
Correlations between number of chronic conditions and baseline measures 
Outcome Measures 









Positive Transfer 0.385* 
Negative Transfer 0.151 
Positive Orientation -0.070 








*p < 0.10, **p < 0.05  
Note: CDSES Chronic Disease Self-efficacy Scale (CDSES) Health-related 
Problem Solving Scale, (HPSS), Medication Adherence Self-efficacy Scale 
(MASES), Morisky Medication Adherence Scale (MMAS), Test of Functional 
Health Literacy in Adults-short form (STOFLHA), World Health Organization 




Associations between psychosocial variables.  Correlational analyses were 
also employed to determine whether there are associations between the baseline 
measures of the primary variable, medication adherence, and secondary variables, 
health literacy, self-efficacy, problem-solving, and QOL (Table 7).   
Medication adherence.  Results indicated that medication adherence (MMAS) 
had negative statistically significant associations with the HPSS Total score (r =-0.489, 
p = 0.024) and HPSS Impulsive/Careless (r =-0.521, p = 0.015).  Higher scores on the 
MMAS are indicative of adherence problems, therefore, in this sample poorer 
adherence was associated with poorer overall health-related problem-solving skills and 
a more impulsive or careless problem-solving style.  Also poorer medication adherence 
was statistically significantly associated with lower quality of one’s living environment (r 
=-0.566, p = 0.009). 
Medication adherence self-efficacy.  A statistically significant positive 
association was found between the MASES and HPSS Positive Orientation/Motivation 
(r = 0.496, p = 0.022).  This indicates that a positive problem-solving orientation is 
associated with greater self-efficacy for following a medication regimen.   
Chronic disease self-efficacy.  There were statistically significant positive 
associations between overall average scores on the CDSES and the Total HPSS score 
(r = 0.593, p = .006), HPSS Positive Orientation subscale (r = 0.483, p = .031), Physical 
QOL (r = 0.684, p = .001), Environmental QOL (r = 0.593, p = .006), and Social QOL (r 
= 0.479, p =.032).  This indicates that  better problem-solving skills and a positive 




self-management.  Also participants who reported better chronic disease self-efficacy 
also reported higher physical, social, and environmental quality of life. 
The overall average on the CDSES was negatively and statistically significantly 
associated with HPSS Avoidant Problem Solving subscale (r = -0.444, p = .050), 
Negative Orientation Subscale (r = -0.537, p = .015).  These results indicate that lower 
self-efficacy for chronic disease self-management was associated with a more avoidant 
problem-solving style and a more negative orientation towards problems.   
Health literacy.  Statistically significant positive associations were found 
between the STOFHLA and CDSES Communicating with Physicians (r = 0.595, p = 
0.007).  This indicates that, in this sample, higher health literacy is associated with 
greater self-efficacy for communicating with providers.   
Health-related problem-solving.  HPSS Total score was statistically 
significantly associated with multiple CDSES subscales including Obtaining Help from 
Community, Family, and Friends (r = 0.443, p = 0.044), Manage Disease in General (r = 
0.759, p < 0.001), Social/Recreational Activities (r = 0.528, p = 0.014), Manage 
Symptoms (r = 0.551, p = 0.010), Manage Depression (r = 0.574, p = 0.006), QOL 
Environment (r = 0.673, p = 0.001) and QOL Social Relationships (r = 0.563, p = 0.010).  
These results indicate that, in this sample, greater health-related problem solving skills 
are associated with greater perceived self-efficacy across multiple chronic disease 
management domains and greater environmental and social quality of life. 
Quality of life.  The QOL Environment subscale had positive statistically 
significant association with the CDSES subscales Manage Disease in General and 




results indicate that as the quality of one’s living environment improves, participants 
tended to report higher self-efficacy for self-managing chronic diseases and their 
symptoms.  Results indicated that there was a positive statistically significant 
association between QOL Social Relationship subscale and the CDSES subscales 
Manage Disease in General and Social/Recreational Activities (r = 0.601, p = 0.005; r = 
0.591, p = 0.006, respectively).  These results indicate that as the quality of one’s social 
life and relationships improves, participants tend to endorse greater self-efficacy for self-






Table 7  
Correlations between baseline measures (N = 20) 
 



























STOFHLA .167 ____              
MASES -.186 .490** ____             
CDSES -.190 -.060 -.141 ____            
HPSS                 
Total -.554** .154 .194 .593* ___           
Effective -.209 .241 .095 .427* .341 ___          
Impulsive .582** .081 -.073 -.287 -.849** -.026 ___         
Avoidant .429* -.069 -.155 -.444** -.861** .024 -.764** ____        
Positive 
Transfer 
-.259 .306 .217 .222 .237 .738** .037 .135 ____       
Negative 
Transfer 
.361 .098 .034 -.314 -.732** .243 .780** .849** .337 ____      
Positive 
Orientation 
-.240 .232 -.500** .407* .581** .390* -.322 -.327 .414* -.087 ___     
Negative 
Orientation 
.381* -.064 -.019 -.465** -.836** .065 -.794** -.871** .238 -.872** -.292 ___    
QOL                
Physical -.443** -.432* -.160 .684** .425* .184 -.254 -.418* -.098 .401* .292 .429* ___   
Psych -.296 -.407* -.146 .279 .067 -.006 -.124 -.059 -.134 -.115 .119 -.033 .541** ___  
Environ -.566** -.073 .072 .593** .673** -.683** -.485** -.441* -.381* -.258 .509** -.377 .598** .445** ___ 
Social -.364 -.058 -.053 .479** .563** -.467** -.501** -.413* .285 -.195 .285 -.405* .339 .018 .533** 
* p < 0.10, ** p  < 0.05 
Note: CDSES Chronic Disease Self-efficacy Scale (CDSES) Health-related Problem Solving Scale, (HPSS), Medication Adherence Self-efficacy Scale (MASES), Morisky 





Post-treatment outcome analyses were conducted for the participants (n = 13) 
who completed both pre- and post-treatment assessments Results are presented in 
Table 8.  Program efficacy was evaluated using within subjects repeated-measures 
means comparison.  Cohen's conventions were used to interpret effect size estimates of 
Cohen’s d (small = .2, medium = .5, large = .8) and confidence intervals for statistically 
significant changes in outcomes.  Given the large number of t-tests, it is expected that if 
all 23 null hypotheses were true, then one would likely be significant due to Type I error 
(determined using the calculation .05(23) = 1.15).   
Medication adherence and self-efficacy.  There were no significant differences 
detected on self-reported medication adherence (MMAS) and self-efficacy (MASES).  
However, there were trends toward significance such that post-treatment self-reported 
medication adherence and self-efficacy were somewhat improved from baseline (p < 
0.10). 
Health-related problem solving.  Results indicated that there were statistically 
significant improvements at post-intervention on the Effective Problem-Solving subscale 
(M = 21.15, SD = 7.39) from baseline (M = 16.15, SD = 7.47), t (12) = 2.50, p = .028, d 
= .69, 95% CI [0.073-1.291].  Also, post-intervention scores (M = 13.23, SD = 3.22) on 
the Positive Transfer subscale statistically significantly improved from baseline scores 
(M = 10.69, SD = 4.29), t (12) = 3.06, p = .010, d = .85, 95% CI [0.197, 1.475].  Both 
improvements were indicative of moderate to large effect sizes.  Results indicated that 
the HPSS Total score also improved, but the change from baseline to post-treatment fell 




Chronic disease self-efficacy.  Results indicated that post intervention scores 
(M = 8.05, SD = 1.63) for self-efficacy for managing chronic disease in general had 
statistically significant improvements from baseline (M = 6.91, SD = 1.84), t (12) = 3.45, 
p = .005, d = .96, 95% CI [0.281-1.606].  Also post-intervention scores for self-efficacy 
for engaging in social/recreational activities (M = 7.92, SD = 1.75) were statistically 
significantly improved from baseline (M = 7.08, SD = 2.22), t (12) = 2.38, p = .005, d = 
.66, 95% CI [0.046, 1.252].  The pre-post change in overall average score on the 
CDSES, and self-efficacy for exercising regularly, and ability to do chores, all fell short 
of statistical significance (p < 0.10). There were no statistically significant differences 
detected on measures of health literacy (STOFHLA) and quality of life (QOL) from 






















M (SD) t p d 
MMAS 5.23 (2.17) 4.08 (1.66) -1.93 0.077*  















































































































































*p < 0.10, **p < .05  
Note: CDSES Chronic Disease Self-efficacy Scale (CDSES) Health-related Problem Solving 
Scale, (HPSS), Medication Adherence Self-efficacy Scale (MASES), Morisky Medication 
Adherence Scale (MMAS), Test of Functional Health Literacy in Adults – short form 
(STOFLHA), World Health Organization Quality of Life scale (QOL) 
 
Predicting medication adherence.  Finally, multiple regression analysis was 
employed to determine whether change in self-efficacy scores uniquely predicts 
medication adherence.  The proposed model included change in self-efficacy scores, 




education.  The model was insignificant indicating that neither change in MASES or 
CDSES scores significantly predicts self-reported medication adherence.   
Post-hoc and Exploratory Results 
Post-hoc analyses were employed to determine whether participants who 
completed the intervention differed from those who did not complete the intervention or 
differed from the original sample on demographic or psychosocial variables.  
Completers (n = 13) were demographically similar and scored similarly on outcome 
measures at baseline when compared to the total sample (N = 20) and when compared 
to those who did not completed the intervention (n = 7).   
Additionally, correlational analyses with the completers sample were employed to 
determine whether the associations reported among baseline variables in the analyses 
of the original sample remained significant.  Generally, the associations and direction of 
relationships reported above remained statistically significant with p < .05 or at a lesser 
magnitude of p < .10.  However, four relationships did not remain significant with the 
completers-only analyses (the number of chronic conditions and health literacy, 
medication adherence and physical health QOL, medication adherence self-efficacy 
with health literacy and problem-solving positive orientation). 
Finally, an exploratory pre-post analysis using an intent-to-treat approach was 
employed.  This included a conservative repeated measures analysis with baseline 
scores of the noncompleters as post-treatment scores.  The results were not 
significantly different than those previously reported.
Chapter VII: Discussion 
Prescription medications are the most common treatment approach for chronic 
conditions.  However, data indicate that about 50% of medications are not taken as 
prescribed and patients and providers frequently endorse adherence to the medication 
regimen as a significant burden and area for improvement among patients.  This study 
adds to the limited research, to date, focused on evaluating effectiveness of behavioral 
interventions for improving medication adherence in this population.  Of note, the 
primary care clinic is the point of care of for many rural patients with MCC and in the 
clinic where this intervention was implemented, the estimated prevalence rate of MCC 
(45%) is almost twice the national estimates (25%). 
Informed by the findings of the pilot survey study (Study 1) the primary aims of the 
intervention study (Study 2) were three-fold: 1) describe demographic and psychosocial 
characteristics of patients with MCC, 2) examine the relationships between number of 
chronic conditions and baseline primary (medication adherence) and secondary (health 
literacy, self-efficacy, problem-solving, and QOL) variables, and 3) examine the 
relationship between primary and secondary variables at baseline and evaluate the 
preliminary efficacy of a medication adherence intervention for patients with MCC on 
improving outcomes. 
Demographic and Psychosocial Characteristics of Patients with MCC 
The first aim of Study 2 was describe the demographic and psychosocial 
characteristics of patients with MCC.  This sample of rural primary care patients 
represented a largely understudied group in the literature.  The sample was 




or disabled.  When compared to current epidemiological research on same-aged peers 
(Anderson, 2010; Boyd & Fortin, 2010), this sample is managing substantially more 
chronic conditions and taking more medications.  The data reported in both studies is, 
however, consistent with research that indicates there is an increasing trend of MCC 
among patients at younger ages  (Mercer, Smith, Wyke, O’Dowd, Watt, 2009) and an 
elevated risk of MCC among rural, low-income, and racial and ethnic minority groups 
(Shi, et al., 2013). 
Study 2 adds to the sparse literature on health literacy in individuals with MCC.  
While the majority of the sample had adequate levels (60%) of health literacy, the 
remaining fell in the inadequate (30%) or marginal (10%) categories.  Individuals who 
have inadequate health literacy are likely to have difficulty understanding instructions 
printed on prescription bottles or instructions for preparing for medical procedures.  
Individuals with marginal health literacy perform better on these tasks but are likely to 
still have difficulty comprehending materials explaining basic rights and responsibilities 
(e.g. insurance informational forms).  The Department of Health and Human Services 
(2003) report indicated that a third of adults have less than adequate health literacy.  
The likelihood of having limited health literacy appears to be greater in this sample than 
in the general population.  This is consistent with other research reporting that ethnic 
minority groups and patients with MCC multiple chronic conditions are more likely to 
have limited health literacy (Morrow et al., 2006).  The prevalence rate of 40% is 
nonetheless concerning because individuals with low health literacy are less likely to 




medication information, and communicate effectively with their providers (Berkman, et 
al., 2011).   
Indeed, the sample in Study 2 reported poor adherence to their medication 
regimen.  In rural populations, barriers to adherence often include financial or 
transportation limitations for obtaining their medications, which could be true of this rural 
low-income sample.  Patients with MCC also report psychological factors for poor 
adherence; specifically, they express uncertainty and conflicting beliefs about 
medication taking (Mc Sharry et al., 2012) and they associate medications with negative 
emotions or loss of personal control (Townsend et al., 2003). 
The results from Study 2 add to the limited literature on problem-solving skills 
and self-efficacy reported by patients with MCC.  This sample had lower total problem-
solving scores, lower scores on subscales measuring effective/positive problem-solving 
and higher scores on ineffective/negative problem-solving subscales compared to the 
scores reported from single disease studies (Hill-Briggs et al., 2007, 2011).  Again, this 
may be due to the complexity that comes with managing MCC and a complicated 
medication regimen.  Notably, scores on measures of chronic disease and medication 
adherence self-efficacy tended to be consistent with normative data (Lorig et al., 1996, 
Ogedegbe, et al., 2003) with the overall average at 7.04 and average baseline scores 
on the chronic disease self-efficacy ranged from 5.62 – 9.21 across domains.  
Participants endorsed higher self-efficacy for communicating with their provider and 
relatively lower self-efficacy for managing depression, managing symptoms, and 




indicated they were, on average, somewhat sure to very sure that they could take their 
medications across most situations.   
This is one of the first investigations using the WHOQOL-BREF scale to evaluate 
QOL in patients with MCC and a predominantly minority sample.  The average baseline 
physical and psychological QOL scores in this sample were two standard deviations 
lower than healthy individuals aged 50-59 years (Hawthorne, Herrman, & Murphy, 2006) 
and one and half standard deviations lower than healthy adults (Skevington & McCate, 
2012).  In a population-based study, Skevington and McCrate (2012) reported data on 
the QOL of patients grouped by various physical or psychological conditions.  The 
current sample’s physical and psychological QOL scores were at least one standard 
deviation lower than patients with diabetes recruited from primary care clinics and 
similar to patients with cardiovascular disease (i.e. history of heart transplant or stroke).  
This sample’s social and environmental QOL scores were similar to normative data on 
healthy samples and subgroups of chronic conditions.  The results of this study indicate 
that, for rural primary care patients with MCC, physical and psychological QOL warrant 
particular attention as areas for future intervention and social and environmental QOL 
could be examined as potential buffers or strengths in studies addressing quality of life 
Collectively, baseline results of Study 2 indicate that patients with MCC report 
limited problem-solving skills and poor medication adherence and poor physical and 
psychological QOL, however scores on self-efficacy measures are consistent with other 
chronic disease populations.  Based on these results and current research, patients with 
MCC may benefit from interventions that focus on improving problem-solving skills and 




Relationships Between Variables at Baseline 
 The second aim of Study 2 was to examine the relationships between the 
number of chronic conditions and primary (medication adherence) and secondary 
variables (health literacy, problem-solving, self-efficacy, and QOL).  It was hypothesized 
that variables would be negatively associated with number of chronic conditions, 
however the results indicated that MCC was not associated with any study variables 
with the exception of health literacy.   
The positive relationship between number of chronic conditions and health 
literacy scores reported in this study is inconsistent with past research (Howard, 
Gazmarariam, & Parker, 2005; Morrow, et al., 2006).  This finding could perhaps be due 
to the fact that patients with MCC have frequent interactions with the health care 
system.  Subsequently, these patients gain experience with and learn how to accurately 
complete the tasks that are assessed by the STOFHLA (e.g. preparing for an x-ray 
appointment).  Also, methodology differences among studies may account for the 
inconsistent reports.  Some studies measure health literacy using the Newest Vital Sign 
(Weiss, et al., 2005), a six-item assessment of quantitative skills and ability to interpret 
information from a nutrition label.  While the NVS and STOFHLA are correlated, they 
assess fundamentally different constructs of health literacy.   
Notably, results from studies using more advanced statistical models indicate 
that the relationship between health literacy and chronic conditions is complex.  One 
study reported that lower health literacy scores are associated with specific conditions 
(e.g. depression, arthritis, hypertension), while there was no associated between health 




studies with primary care patients indicate that other important psychosocial and 
demographic variables such as age, income, and cognitive abilities (i.e. processing 
speed) account for variance in health literacy scores (Hudon et al., 2012; Morrow et al., 
2006).  Although the research consistently states that health literacy is important factor 
influencing self-management and health outcomes, more research is needed to 
elucidate important factors that contribute to health literacy in this population. 
The lack of association between MCC and medication adherence scores is also 
inconsistent with past research (Gallacher et al., 2014; Roter et al., 1998).  The 
relationship between MCC and adherence may be better explained as a dichotomy 
such that that once patients are diagnosed with a certain number of chronic conditions 
they are at a significantly greater risk of having poor medication adherence.  Indeed, 
participants had on average 5 chronic conditions and reported poor adherence, which 
supports the theory that patients with more than one chronic condition are likely to have 
poor adherence.  Perhaps once patients are managing MCC, factors other than number 
of chronic conditions are better indicators of adherence such as number of medications, 
health insurance/prescription assistance, or presence of a mental health disorder. 
The second aim of Study 2 also hypothesized that there would be positive 
associations between the outcome variables, medication adherence, self-efficacy, 
problem-solving, and quality of life in patients with MCC.  The results indicated that 
problem-solving was associated with medication adherence, medication adherence self-
efficacy, and overall CDSES and CDSES domains for obtaining help from family, 
friends, and community, managing chronic disease in general, and managing 




problem solving is associated with better adherence and an impulsive problem solving 
approach is associated with poorer adherence (see review Hill-Briggs, 2003).  Also 
consistent with diabetes and multimorbidity research, are the positive associations 
between total problem-solving score and the positive orientation subscale with CDSES 
and medication adherence self-efficacy, respectively.  Previous research with this 
population indicates that patients who report a sense of losing control over their health 
and low self-efficacy for managing health report greater difficulty adhering to their 
regimen (Aljasem, Peyrot, Wissow, Rubin, 2001; Mc Sharry et al., 2012).  In contrast, 
problem-solving theory asserts that individuals with a positive problem solving 
orientation view problems as learning opportunities have positive expectation and high 
self-efficacy (Cook, 2006).   
Furthermore, research with diabetes and HIV populations indicate that higher 
Total HPSS scores are associated with better disease outcomes (i.e. A1C and CD4; 
Hill-Brigg et al., 2007) and decreased hospitalizations.  While health outcome and 
health care utilization variables were not measured in this study, HPSS scores tended 
to be lower which may be indicative of patient risk for poor outcomes and greater 
hospitalizations in this sample. This is one of the first studies to examine the relationship 
between HPSS scores, adherence, self-efficacy, and QOL, more research is needed to 
explore how health-related problem solving skills influence adherence and disease 
outcomes in this population.   
The lack of association between medication adherence and self-efficacy has 
been reported in other research (Rubin, 2005, Sarkar, Fisher, & Schillinger, 2006).  This 




treatment factors (e.g. medication side effects, regimen complexity), and demographic 
and broader systemic factors (economic, access to and quality of health care) may 
mediate or moderate the relationship between self-efficacy and adherence in this 
population.  Indeed, in this study problem-solving orientation and skills were associated 
with both medication adherence and several domains of chronic disease self-efficacy.  
Research using more sophisticated analyses to elucidate these relationships is 
warranted. 
The finding that greater environmental and social QOL of life was associated with 
higher self-efficacy for managing chronic disease and better problem-solving skills is 
consistent with the research (Hill-Briggs & Gemmell, 2007; Marks et al., 2005).  In a 
review Marks and colleagues report that self-efficacy for chronic disease self-
management is associated with quality of life and influences patients perception of their 
quality of life.  Additionally, interventions that target improvements in self-efficacy and 
include a problem-solving component have been shown to improve quality of life for 
patients with chronic conditions.  While many studies with health populations use the 
SF-36, the “gold standard” measure of QOL, the WHOQOL is unique in its ability to 
assess environmental QOL, which is a lesser studied but important factor contributing to 
health care management.  Indeed, public health research indicates that community and 
environmental variables such as poverty and neighborhood violence play a role in risk 
of morbidity and poor health behaviors (Davey-Smith et al., 1998).  Given that this 
sample had normative environmental QOL scores, this study provides some clarity with 





Intervention Efficacy on Psychosocial Outcomes 
 The third aim of Study 2 sought to evaluate the preliminary efficacy of a pilot 
intervention for improving medication adherence.  The hypotheses that medication 
adherence, medication self-efficacy, and QOL scores would improve significantly from 
baseline to post-treatment were not supported.  The hypotheses that chronic disease 
self-efficacy and HPSS would improve from baseline to post-treatment was supported 
for subscales on each measure.  Results indicated that post-treatment scores 
significantly improved from baseline on measures of HPSS subscales effective problem 
solving and positive transfer problem solving and self-efficacy for engaging in chronic 
disease self-management and social/recreational activities.   
 Although there has been recent emphasis placed on increasing research with 
patients with MCC and interventions to improve medication adherence, there are very 
few studies that are directly comparable to the current intervention.  As reported in 
previous reviews (Haynes et al., 2013; Williams et al., 2008) existing medication 
adherence interventions vary in duration (from one point of contact to weekly for six 
months), method (e.g. who delivers it, individual or group mode), and medium (e.g. in 
person, telephone or print media).  Moreover, many interventions are limited in that they 
only provide education and, if additional counseling is offered, strategies are rarely 
developed from a theoretical framework.    
The hypothesis that the primary outcome variable, medication adherence, would 
significantly improve was not supported.  While self-reported medication adherence 
improved, this change fell short of significance (p = 0.077).  A study with renal transplant 




improvements in medication adherence as measured by electronic monitoring, however 
improvements were not maintained at six month follow-up (De Geest et al., 2006).  This 
study was similar to the current study in that it included specific strategies for improving 
medication adherence education, problem-solving, and goal-setting.  However, it 
differed in modality, as there were only four monthly interventionist contacts (one in-
home session with the patient and family and three telephone follow-up sessions) and 
researchers did not assess for self-reported self-efficacy or problem-solving.  The 
current study is novel as it assesses self-efficacy and problem-solving which have been 
theoretically linked to adherence and self-management behaviors.  Thus, it provides 
valuable data and helps fill gaps in the research investigating if and how these factors 
drive changes in patient adherence behaviors.  In order to better assess medication 
adherence behaviors future studies may include an additional measure of adherence 
(e.g. prescription refill data, electronic pill monitoring).  Additionally longer follow-up (i.e. 
more telephone sessions, during visits with primary care provides) would allow for more 
individualized feedback and skill-building that could enhance improvements in 
medication adherence behaviors. 
Self-reported self-efficacy for engaging in chronic disease self-management and 
social activities improved significantly.  This suggests that participants felt more 
confident in their ability to act in ways that are consistent with good self-management 
and participate in social activities.  There are many reasons why participation in the 
current intervention may have improved self-efficacy in these domains.  Past research 
has shown that poor self-efficacy for self-management is associated with limited health 




(Mc Sharry et al., 2012).  Therefore, intervention was designed to improve self-efficacy 
through improving health literacy for understanding prescriptions and improving 
cognitive-behavioral skills for managing health.  Additionally, behavioral training was 
provided on how to self-monitor health behaviors, use a pill organizer and create a 
simplified individualized dosing schedule.  These aspects of the intervention may have 
contributed to improvements in patients feelings of control over their regimen, functional 
health literacy, as well as the moderate to large effects on self-efficacy for general 
chronic disease self-management (d = 0.66).  Indeed, Conn and colleagues reported 
that interventions that include succinct instructions on medication taking were more 
effective (mean d = 0.61) compared to those without instructions (mean d = 0.29).  
Lastly, the small to moderate effects (d = 0.46) on self-efficacy for engaging in social 
activities may be explained by the focus on improving problem orientation as well as the 
positive experiences obtained by participating in a group-based program. 
Significant improvements in effective problem-solving skills indicates that 
participants became more skilled at using a rational process of sequential steps for 
identifying a problem, examining solutions and barriers, acting on solutions, and 
learning from the experience.  Relatedly, improvements in HPSS positive transfer 
subscale suggests that participants reported improved ability to transfer knowledge from 
past experiences to new situations.  Two of the four group sessions focused on 
improving problem-solving orientation and skills using culturally and low literacy tailored 
strategies.  This approach is consistent with the research reporting that interventions 
targeting problem solving effectively improve health outcomes; specifically, larger effect 




= 1.00) and assign homework (d = 1.02, Malouff et al., 2007).  In this study, the effect 
sizes for improving problem-solving orientation and positive transfer were 0.69 and 
0.85, respectively, which is greater than current medication adherence interventions 
using a combination of educational and behavioral strategies (d = 0.56).  More research 
is needed to elucidate how effective strategies from problem-solving therapy can be 
adapted for interventions for patients managing MCC and complex medication 
regimens. 
Limitations 
 Study 2 is not without its limitations including small sample size and attrition, 
assessment methods, and lack of a usual care or control group.  The results should be 
interpreted within the context of these limitations.   
The small sample size in these studies significantly limits the power and 
increases the risk of Type II error.  With low power it is possible that significant 
associations and intervention effects could not be detected.  Future studies with larger 
sample sizes can help determine whether the findings that fell short of significance 
would rise to significance.  Additionally, the significant findings and moderate to large  
effect size,!reported in the Study 2 suggest that more studies are needed to evaluate 
whether the associations and intervention effectiveness can be replicated.   
The small sample size could have resulted from a number of factors that are 
particularly salient in a rural primary care clinic environment, such as ineffective 
recruitment and enrollment methods and difficulty retaining participants.  Despite use of 
recommended strategies to enhance recruitment and retention (Burns, et al., 2008), 




when sample size was affected by attrition.  Flyer advertisements did not appear to be 
effective as nearly all referrals came from providers (118/119).  While providers made 
many referrals, the majority of these patients were not interested (55%).  Some 
methods that may improve recruitment in future studies include identifying patients who 
have MCC and a high number of prescriptions or asking all patients with MCC who 
present for care to complete a one-item questionnaire asking about interest in the 
program or medication adherence. 
Additionally, only 29 of the 54 patients with MCC (54%) who scheduled an 
appointment for an interest meeting actually attended.  In this population transportation 
is common barrier for engagement (Burns, et al., 2008) and this may have contributed 
to why many did not attend the initial meeting.  Although the program offered 
transportation to patients after enrollment, only 2 participants used the van transport 
option.  It is possible that many of the patients who expressed interest would have 
attended the initial meeting and enrolled if transportation were offered for the initial 
meeting.  Once patients attended the interest meeting more than two thirds enrolled 
which suggests that patients with MCC who are interested and attend the initial meeting 
are likely to enroll in the program.  Research that investigates effective methods for 
recruitment and explores barriers for retention is needed.   
Compared to a previous study in this setting the attrition rate of 35% is slightly 
improved, and dropped to 15% after participants attended the first group meeting.  
However it is greater than rates reported in previous studies (Haynes et al., 2008).  It is 
recommended for future studies that the time between enrollment and the first group 




or stage of change is decreased.  Nonetheless, some attrition is to be expected in this 
population as economic and social stressors that impact participation rates tend to be 
more prevalent (Loftin, et al., 2005)  
Measurement limitations also need to be considered in the context of current 
findings.  There is significant psychometric research on measuring medication 
adherence.  Research indicates that patients provide inaccurate accounts of their 
adherence due to poor insight and motivation to be perceived positively (DiMatteo, 
2004).  However, self-report remains the most common method because it is practical 
and low cost.  Further other methods such as electronic monitoring of pill bottles and 
pharmacy refills are expensive and have their own limitations to provide accurate 
measures of medication-taking behavior.  Moreover, Thorpe and colleagues (2009) 
reported that symptom control was similarly predicted by an objective measure of 
medication adherence (i.e. refill rates at a pharmacy) and self-report.  It is likely that the 
poor adherence reported by participants in this study is accurate as some research 
indicates that if a person endorses poor adherence then it is likely an accurate report 
(Choo et al., 1999).  Moreover, the results of the current study may be an 
underestimation of the improvement in medication adherence .  Based on current 
research, self-reported medication adherence scores at baseline are likely an 
overestimation of actual adherence and scores at post-treatment may be more accurate 
due to improvements in insight knowledge and behaviors that were gained during the 
intervention from self-monitoring and other learned strategies. 
Another limitation in measurement is the tool used to assess medication 




demonstrated that it is limited in its variability and predictive power (Fernandez, Chaplin, 
Shoenthaler, & Ogdegbe, 2008).  The MASES-R was validated using two forms of 
medication adherence data (self-reported adherence and electronic monitoring).  
Notable revisions including reduce the questionnaire to 13 items and the response 
options have been expanded from a 3- to a 4-point scale.  Specifically the expansion 
removed the somewhat sure response option and, in its place, are the options a little 
sure and fairly sure.  Preliminary research with the MASES-R demonstrated that the 
expanded the response scale provides more information about which individuals report 
very low to moderately low self-efficacy.  Thus, the revised version demonstrates 
improved utility in practice and research over its original version with regard to 
identifying individuals who may benefit from intervention and measuring change in self-
efficacy over time.  In the current study the average score on the MASES is 2.25 (SD = 
0.43), meaning that responses fell around somewhat sure.  Future study with the 
MASES-R in this population is needed to assess for patients with very low or moderate 
self-efficacy.   
Finally, Study 2 is limited due to the pre-post test design and lack of a control or 
usual care group.  Without a control group it is difficult to say with certainty that the 
significant changes are due solely to the effects of the intervention.  Improvements may 
be attributed to health changes that can affect motivation to take medications or the 
Hawthorne effect, which accounts for participant behavior change that is due to 
awareness of being observed.  Nonetheless, the pre-post study design is appropriate 





Conclusions and Future Directions 
Further research with patients with MCC and medication adherence is sorely 
needed.  In conclusion, Studies 1 and 2 make a significant contribution to a limited but 
growing literature base.  Although Study 2 raises more questions than it answers about 
relationships between variables and methods of intervention in this population.  Future 
studies need to investigate whether variables other than number of chronic conditions 
are better indicators of adherence.  Relatedly, more sophisticated analyses are needed 
to elucidate the relationship between quality of life, health literacy, self-efficacy, and 
medication adherence.  Findings from this research may help inform which patients 
might benefit from intervention as well as potential barriers to adherence and targets for 
intervention. 
The frequently cited randomized controlled trials by Lorig and colleagues (1999, 
2005) is a self-efficacy based group intervention (i.e. CDSMP) that resulted in significant 
and sustained reductions in participant health distress and improvements in health care 
utilization.  The intervention in the current study was similar as it combined and adapted 
evidence-based strategies from the single-disease literature in order to improve self-
efficacy in patients with MCC.  However, the CDSMP was designed to improve multiple 
health behaviors, while the current study was innovative in its aim to specifically 
enhance self-efficacy for medication adherence.  These studies provide a foundation 
from which future investigations can be developed that test specific hypotheses about 





 Further, the current investigation was novel as it was designed to be brief and 
practical for low-resource primary care settings like FQHCs.  The frequency, dose, and 
duration of many programs is impractical for this setting (e.g. CDSMP’s 2.5 hr sessions 
that occur weekly for 7 weeks).  Future studies need to evaluate variations in 
intervention intensity in order to determine the most effective dosing schedule that 
facilitates clinically and statistically significant change in self-efficacy and health 
outcomes.  Researchers also need to provide information on effective methods for 
collaborating with stake-holders and providers and maintaining program feasibility in the 
primary care context.  This research would have significant implications with regard to 
program implementation and improvements on clinical outcomes.   
In sum, participants in the intervention experienced improvements on measures 
of medication adherence, health-related problem-solving, medication adherence self-
efficacy, and chronic disease self-efficacy, however some positive changes fell short of 
statistical significance.  Studies with larger samples sizes and more sophisticated 
designs are needed to establish the efficacy of this intervention, as well as the durability 
and magnitude of treatment effects.  This larger scale research needs to also assess for 
changes in disease-specific and multiple morbidity clinical outcomes and health care 
utilization. 
REFERENCES 
Administration on Aging (2011). Profile of older Americans: Aging statistics. Retrieved 
from http://www.aoa.gov/aoaroot/aging_statistics/index.aspx 
Aljasem, L. I., Peyrot, M., Wissow, L., & Rubin, R. R. (2001). The impact of barriers and 
self-efficacy on self-care behaviors in type 2 diabetes. Diabetes Education, 27, 
393-404. doi: 10.1177/014572170102700309  
American Association of Diabetes Educators (2011). American Association of Diabetes 
Educators (AADE) Position Statement - AADE7. Retrieved from 
http://www.diabeteseducator.org/ProfessionalResources/AADE7/ 
Anderson, R. M., Funnell, M. M., Butler, P. M., Arnold, M. S., Fitzgerald, J. T., & Feste, 
C. C. (1995). Patient empowerment: Results of a randomized controlled trial. 
Diabetes Care, 18, 943-949. doi: 10.2337/diacare.18.7.943  
Anderson, G. (2010). Chronic care: Making the case for ongoing care. Princeton, NJ: 
Robert Woods Johnson Foundation. 
Anderson-Rothman, A., & Wagner, E. H. (2003). Chronic illness management: What is 
the role of primary care? Annals of Internal Medicine, 138, 256. doi:  
10.7326/0003-4819-138-3-200302040-00034  
Arnold, M. S., Butler, P. M., Anderson, R. M., Funnell, M. M., & Feste, C. (1995). 
Guidelines for facilitating a patient empowerment program. The Diabetes 
Educator, 21, 308-312. doi: 10.1177/014572179502100408  
Baker D. W., Williams M. V., Parker R. M., Gazmararian J. A., & Nurss J. (1999). 
Development of a brief test to measure functional health literacy. Patient 
Education & Counseling, 38, 33-42. doi: 10.1016/s0738-3991(98)00116-5  
Bandura, A. (1986). Social foundations of thought and action: A social cognitive theory. 
Englewood Cliffs, NJ: Prentice Hall.  
Bandura, A. (1991). Social cognitive theory of self-regulation. Organizational Behavior 
and Human Decision Processes, 50, 248-287. doi: 10.1016/0749-
5978(91)90022-L 
Bandura, A. (1997). Self-Efficacy: The exercise of control. New York, NY: Freeman. 
Barlow, J., Wright, C., Turner, A., & Bancroft, G. (2005). A 12-month follow-up study of 
self-management training for people with chronic disease: Are changes 





Barlow, J., Wright, C., Sheasby, J., Turner, A., & Hainsworth, J. (2002). Self-
management approaches for people with chronic conditions: A review. Patient 
Education & Counseling, 48, 177-187. doi: 10.1016/S0738-3991(02)00032-0 
Bayliss, E. A., Bayliss, M. S., Ware, J. E., & Steiner, J. F. (2004). Predicting declines in 
physical function in persons with multiple chronic medical conditions: What we 
can learn from the medical problem list. Health and Quality of Life Outcomes, 2, 
47. doi: 10.1186/1477-7525-2-47 
Bayliss, E. A., Ellis, J. L., & Steiner, J. F. (2007). Barriers to self-management and 
quality-of-life outcomes in seniors with multimorbidities. The Annals of Family 
Medicine, 5, 395-402. doi: 10.1370/afm.722 
Beacham, A., Herbst, A., Streitwieser, T., Scheu, E., & Sieber, W. (2012) Primary care 
medical provider attitudes regarding mental health and behavioral medicine in 
integrated and non-integrated primary care practice settings. Journal of Clinical 
Psychology in Medical Settings, 19, 364-375. doi: 10.1007/s10880-011-9283-y 
Beck, J. (2011). Cognitive behavior therapy: Basics and beyond (2nd Ed.). New York 
NY: Guilford Press. 
Berkman, N. D., Sheridan, S. L., Donahue, K. E., Halpern, D. J., & Crotty, K. (2011). 
Low health literacy and health outcomes: An updated systematic review. Annals 
of Internal Medicine, 155, 97-107. doi: 10.7326/0003-4819-155-2-201107190-
00005  
Bodenheimer, T. & Handley, M. A. (2009). Goal-setting for behavior change in primary 
care: An exploration and status report. Patient Education and Counseling, 76, 
174-180. doi: 10.1016/j.pec.2009.06.001  
Bodenheimer, T., Lorig, K., Holman, H., & Grumbach, K. (2002). Patient self-
management of chronic disease in primary care. Journal of the American Medical 
Association, 288, 2469-2475. doi: 10.1001/jama.288.19.2469 
Bogner, H. R., & de Vries, H. F. (2008). Integration of depression and hypertension 
treatment: A pilot randomized controlled trial. The Annals of Family Medicine, 6, 
295-301. doi: 10.1370/afm.843  
Boswell, K. A., Cook, C. L., Burch, S. P., Eaddy, M. T., & Cantrell, C. R. (2012). 
Associating medication adherence with improved outcomes: A systematic 
literature review. American Journal of Pharmacy Benefits, 4, e97-e108. Retrieved 
from 
http://www.ajpblive.com/media/pdf/AJPB_12julaug_Boswell_e97to108apdx.pdf. 
Boyd, C. M., & Fortin, M. (2010). Future of multimorbidity research: How should 




Review, 32, 451-474. Retrieved from 
http://www.publichealthreviews.eu/upload/pdf_files/8/PHR_32_2_Boyd.pdf 
Boyer, B. A. (2008). Diabetes. In Boyer, B. A., & Paharia, M. I. (Eds.). Comprehensive 
handbook of clinical health psychology (179-200). Hoboken, NJ: Wiley. 
Brus, H., van de Laar, M., Taal, E., Rasker, J., & Wiegman, O. (1999). Determinants of 
compliance with medication in patients with rheumatoid arthritis: The importance 
of self-efficacy expectations. Patient Education and Counseling, 36, 57-64. doi: 
10.1016/S0738-3991(98)00087-1  
Buchner, A., Erdfelder, E., & Faul, F. (1997). How to Use G*Power. Retrieved from 
http://www.psycho.uniduesseldorf.de/aap/projects/gpower/how_to_use_gpower.h
tml 
Burns, D., Skoward, A. C. M., Skelly, A. H., Leemon, J., & Carlson J. (2008). Effective 
recruitment and retention strategies for older members of rural minorities. The 
Diabetes Educator, 34, 1045-1052. 
Center for Disease Control (2011) National Center for Chronic Disease Prevention and 
Health Promotion, Division of Diabetes Translation. Retrieved from 
http://www.cdc.gov/diabetes/atlas/countydata/atlas.html 
Choo P. W., Rand C. S., Inui T. S., et al., (1999). Validation of patient reports, 
automated pharmacy records, and pill counts with electronic monitoring of 
adherence to antihypertensive therapy. Medical Care, 37, 846-57. doi: 
10.1097/00005650-199909000-00002  
Clancy, C. M. (2011). Patient engagement in health care. Health Services Research, 
46, 389-393. doi: 10.1111/j.1475-6773.2011.01254.x  
Clark, N. M., Becker, M. H., Janz, N. K., Lorig, K., Rakowski, W., & Anderson, L. (1991). 
Self-management of chronic disease by older adults: A review and questions for 
research. Journal of Aging and Health, 3, 3-27. 
doi:10.1177/089826439100300101  
Conn, V. S., Hafdahl, A. R., Cooper, P. S., Ruppar, T. M, Mehr, D. R., & Russell, C. L. 
(2009). Interventions to improve medication adherence among older adults: 
Meta-analysis of adherence outcomes among randomized controlled trials. The 
Gerontologist, 49, 447-462. doi: 10.1093/geront/gnp037  
Cook, P. F., (2006). Adherence to Medications. In W.T. O’Donohue & E. R. Levensky. 
(Eds.) Promoting treatment adherence: A practical handbook for health care 




Daniels, L.M., Dixon, K., Campbell, L.C. (2014). Building capacity for behavioral health 
services and clinical research in a rural primary care clinic: A case study. Aims 
Public Health, 1 (2), 60-75. doi: 10.3934/publichealth.2014.2.60  
D'Zurilla, M. R. & Goldfried T. J. (1971). Problem solving and behavior modification. 
Journal of Abnormal Psychology, 78, 107–126. doi: 10.1037/h0031360  
D'Zurilla, T. J., & Nezu, A. (1999). Problem-solving therapy: A social competence 
approach to clinical intervention. New York, NY: Springer Publishing Co. 
Damschroder, L. J., Lutes, L. D., Goodrich, D. E., Gillon, L., & Lowery, J. C. (2010). A 
small-change approach delivered via telephone promotes weight loss in 
veterans: Results from the ASPIRE-VA pilot study. Patient Education and 
Counseling, 79, 262-266. doi: 10.1016/j.pec.2009.09.025  
Davey-Smith, G., Hart, C., Watt, G., Hole, D., & Hawthorne, V. (1998). Individual social 
class, area-based deprivation, cardiovascular disease risk factors, and mortality. 
Journal of Epidemiology and Community Health, 52, 399-405. doi: 
10.1136/jech.52.6.399  
De Geest, S., Schäfer-Keller, P., Denhaerynck, K., Thannberger, N., Köfer, S., Bock, A., 
. . . Steiger, J. (2006). Supporting medication adherence in renal transplantation 
(SMART): A pilot RCT to improve adherence to immunosuppressive regimens. 
Clinical Transplantation, 20, 359-368. doi: 10.1111/j.1399-0012.2006.00493.x  
DeSalvo, K. B., Bloser, N., Reynolds, K., He, J., & Muntner, P. (2005). Mortality 
prediction with a single general self‐rated health question. Journal of General 
Internal Medicine, 21, 267-275. doi: 10.1111/j.1525-1497.2005.00291.x 
DiMatteo, M. R. (2004). Variations in patients' adherence to medical recommendations: 




Edwards, M., Wood, F., Davies, M., & Edwards, A. (2012). The development of health 
literacy in patients with a long-term health condition: The health literacy pathway 
model. BMC Public Health, 12, 130. doi: 10.1186/1471-2458-12-130  
Evers, K. E., & Quintiliani, L. M. (2013). Advances in multiple health behavior change 
research. Translational Behavioral Medicine, 3, 59-61. doi: 10.1007/s13142-013-
0198-z  
Fortin, M., Bravo, G., Hudon, C., Lapointe, L., Almirall, J., Dubois, M., & Vanasse, A. 




patients in primary care. Quality of Life Research, 15, 83-91. doi: 
10.1007/s11136-005-8661-z  
Fortin, M., Stewart, M., Poitras, M. E., Almirall, J., & Maddocks, H. (2012). A systematic 
review of prevalence studies on multimorbidity: Toward a more uniform 
methodology. The Annals of Family Medicine, 10, 142-151. doi: 
10.1370/afm.1337  
Gallacher, K. I., Batty, G. D., McLean, G., Mercer, S. W., Guthrie, B., May, C. R., ... 
Mair, F. S. (2014). Stroke, multimorbidity and polypharmacy in a nationally 
representative sample of 1,424,378 patients in Scotland: Implications for 
treatment burden. BMC Medicine, 12, 151. doi: 10.1186/preaccept-
1272432928127782  
Gijsen, R., Hoeymans, N., Schellevis, F. G., Ruwaard, D., Satariano, W. A., & van den 
Bos, G. A. (2001). Causes and consequences of comorbidity: A review. Journal 
of Clinical Epidemiology, 54, 661-674. doi: 10.1016/s0895-4356(00)00363-2  
Glasgow, R. E., Fisher, L., Skaff, M., Mullan, J., & Toobert, D. J. (2007). Problem 
solving and diabetes self-management: Investigation in a large, multiracial 
sample. Diabetes Care, 30, 33-37. doi: 10.2337/dc06-1390  
Glasgow, R. E., Klesges, L. M., Dzewaltowski, D. A., Bull, S. S., & Estabrooks, P. 
(2004). The future of health behavior change research: What is needed to 
improve translation of research into health promotion practice? Annals of 
Behavioral Medicine, 27, 3-12. doi: 10.1207/s15324796abm2701_2  
Glasgow, R. E., Toobert, D. J. & Gillette, C. D. (2001). Psychosocial barriers to diabetes 
self-management and quality of life. Diabetes Spectrum, 14, 33. doi: 
10.2337/diaspect.14.1.33  
Glazier, R. H., Bajcar, J., Kennie, N. R., & Willson, K. (2006). A systematic review of 
interventions to improve diabetes care in socially disadvantaged populations 
Diabetes Care, 29, 1675-1688. doi: 10.2337/dc05-1942  
Gonder-Frederick, L. A., Cox, D. J., & Ritterband, L. M. (2002). Diabetes and behavioral 
medicine: The second decade. Journal of Consulting and Clinical Psychology, 
70, 611–625. doi: 10.1037//0022-006x.70.3.611  
Gonzalez, J. S., Fisher, L., & Polonsky, W. H. (2011). Depression in diabetes: Have we 
been missing something important? Diabetes Care, 34, 236-239. 
doi:10.2337/dc10-1970  
Griffin, S. (1998). Educational and psychosocial interventions for adults with diabetes: A 
survey of the range and types of interventions, the extent to which they have 




as reported in existing reviews. Report to the British Diabetic Association, Final 
Draft, June 1998. British Diabetic Association. 
Hawthorne, G., Herrman, H., & Murphy, B. (2006). Interpreting the WHOQOL-BREF: 
Preliminary population norms and effect sizes. Social Indicators Research, 77, 
37-59. doi: 10.1007/s11205-005-5552-1  
Haynes, R. B., Ackloo, E., Sahota, N., McDonald, H. P., & Yao, X. (2008). Interventions 
for enhancing medication adherence. England: John Wiley & Sons. doi: 
10.1002/14651858.CD000011.pub3  
Hays, R. D., Wells, K. B., Sherbourne, C. D., Rogers, W., & Spritzer, K. (1995). 
Functioning and well-being outcomes of patients with depression compared with 
chronic general medical illnesses. Archives of General Psychiatry, 52, 11. doi: 
10.1001/archpsyc.1995.03950130011002  
Hill-Briggs, F. (2003). Problem solving in diabetes self-management: A model of chronic 
illness self-management behavior. Annals of Behavioral Medicine, 25, 182-193. 
doi: 10.1207/s15324796abm2503_04  
Hill-Briggs, F., & Gemmell, L. (2007). Problem solving in diabetes self-management and 
control: A systematic review of the literature The Diabetes Educator, 33, 1032-
1052. doi: 10.1177/0145721707308412  
Hill-Briggs F., Gemmell L., Kulkarni B., Klick B., & Brancati F.L. (2007). Associations of 
patient health-related problem solving with disease control, emergency 
department visits, and hospitalizations in HIV and diabetes clinic samples. 
Journal of General Internal Medicine, 22, 649–654. doi: 10.1007/s11606-006-
0091-2  
Hill-Briggs, F., Lazo, M., Peyrot, M., Doswell, A., Chang, Y. T., Hill, M. N., . . . Brancati, 
F. L. (2011). Effect of problem-solving-based diabetes self-management training 
on diabetes control in a low income patient sample. Journal of General Internal 
Medicine, 26, 972-978. doi: 10.1007/s11606-011-1689-6  
Hill-Briggs, F., Renosky, R., Lazo, M., Bone, L., Hill, M., Levine, D., . . . Peyrot, M. 
(2008). Development and pilot evaluation of literacy-adapted diabetes and CVD 
education in urban, diabetic African Americans. Journal of General Internal 
Medicine, 23, 1491-1494. doi:10.1007/s11606-008-0679-9. 
Hudon, C., Fortin, M., Poitras, M. E., & Almirall, J. (2012). The relationship between 
literacy and multimorbidity in a primary care setting. BMC Family Practice, 13, 
33. doi: 10.1186/1471-2296-13-33  
Institute of Medicine (2004). Health literacy: A prescription to end confusion. National 




Institute of Medicine (2012). Multiple chronic conditions & clinical practice guideline 
meetings. Retrieved from http://iom.edu/Activities/Quality/VSRT/2012-MAY-
29.aspx. 
Krichbaum, K., Aarestad, V., & Buethe, M. (2003). Exploring the connection between 
self-efficacy and effective diabetes self-management. The Diabetes Educator, 
29, 653-662. doi: 10.1177/014572170302900411  
Kripalani S., Yao X., & Haynes R. (2007). Interventions to enhance medication 
adherence in chronic medical conditions: A systematic review. Archives of 
Internal Medicine, 167, 540-549. doi: 10.1001/archinte.167.6.540. 
Krousel-Wood M., Thomas S., Muntner P., & Morisky, D. (2004). Medication adherence: 
A key factor in achieving blood pressure control and good clinical outcomes in 
hypertensive patients. Current Opinion in Cardiology, 19, 357-362. doi: 
10.1097/01.hco.0000126978.03828.9e  
Kuhajda M.C., Thorn B.E., Gaskins S.W., Day M.A., & Cabbil C.M. (2011). Literacy and 
cultural adaptations for cognitive behavioral therapy in a rural pain population. 
Translational Behavioral Medicine: Practice, Policy and Research,1, 216-223. 
doi: 10.1007/s13142-011-0026-2  
Kutner, M., Greenburg, E., Jin, Y., & Paulsen, C. (2006). The health literacy of 
America's adults: Results from the 2003 National Assessment of Adult Literacy. 
NCES 2006-483. National Center for Education Statistics. doi: 
10.1037/e530912012-001  
Lazarus, R. S., & Folkman, S. (1984). Stress, appraisal, and coping. New York: 
Springer. 
Leeman, J., Skelly, A. H., Burns, D., Carlson, J., & Soward, A. (2008). Tailoring a 
diabetes self-care intervention for use with older, rural African American women. 
The Diabetes Educator, 34, 310-317. doi: 10.1177/0145721708316623  
Leventhal, H., Leventhal, E. A., & Breland, J. Y. (2011). Cognitive science speaks to the 
‘Common-Sense’ of chronic illness management. Annals of Behavioral Medicine, 
41, 152–163. doi: 10.1007/s12160-010-9246-9  
Leventhal, H., Meyer, D., & Nerenz, D. (1980). The common sense representation of 
illness danger. S. Rachman (Ed.), Contributions to medical psychology (2nd ed., 
pp. 7–30). New York, NY: Pergamon Press. 
Loftin, W. A., Barnett, S. K., Bunn, P. S., Sullivan, P. (2005). Recruitment and retention 
of rural African Americans in diabetes research: Lessons learned. Diabetes 




Lorig, K. R., & Holman, H. R. (2003). Self-management education: History, definition, 
outcomes, and mechanisms. Annals of Behavioral Medicine, 26, 1-7. doi: 
10.1207/s15324796abm2601_01  
Lorig, K., Ritter, P., & Jacquez, A. (2005). Outcomes of border health Spanish/English 
chronic disease self-management programs. Diabetes Educator, 31, 401-409. 
doi: 10.1177/0145721705276574  
Lorig, K., Ritter, P., & Plant, K. (2005). A disease-specific self-help program compared 
with a generalized chronic disease self-help program for arthritis patients. 
Arthritis & Rheumatism-Arthritis Care & Research, 53, 950-957. doi: 
10.1002/art.21604  
Lorig K., Stewart A.L., Ritter P. (1996) Outcome measures for health education and 
other health care interventions. Thousand Oaks, CA: Sage Publications. 
Lutes, L. D., Daiss, S. R., Barger, S. D., Read, M., Steinbaugh, E., & Winett, R. A. 
(2012). Small changes approach promotes initial and continued weight loss with 
a phone-based follow-up: Nine-month outcomes from ASPIRES II. American 
Journal of Health Promotion, 26, 235-238. doi: 10.4278/ajhp.090706-quan-216  
Lutes, L. D., & Steinbaugh, E. K. (2010). Theoretical models for pedometer use in 
physical activity interventions. Physical Therapy Reviews, 15, 143-153. doi: 
10.1179/1743288X10Y.0000000002  
Malouff, J. M., Thorsteinsson, E. B., & Schutte, N. S. (2007). The efficacy of problem 
solving therapy in reducing mental and physical health problems: A meta-
analysis. Clinical Psychology Review, 27, 46-57. doi:10.1016/j.cpr.2005.12.005  
Marks, R., Allegrante, J. P., & Lorig, K. (2005). A review and synthesis of research 
evidence for self-efficacy-enhancing interventions for reducing chronic disability: 
Implications for health education practice (part I). Health Promotion Practice, 6, 
37-43. doi:10.1177/1524839904266790  
Marks, R., Allegrante, J. P., & Lorig, K. (2005). A review and synthesis of research 
evidence for self-efficacy-enhancing interventions for reducing chronic disability: 
Implications for health education practice (part II) Health Promotion Practice, 6, 
148-156. doi:10.1177/1524839904266792  
McInnis, T., Webb, E., & Strand. L. (2012, June). The patient centered primary care 
collaborative: Integrating comprehensive medication management to optimize 
patient outcomes resource guide. (2nd ed.).  Washington D.C.: Patient Centered 





Mc Sharry, J., Bishop, F. L., Moss-Morris, R., & Kendrick, T. (2013). 'The chicken and 
egg thing': Cognitive representations and self-management of multimorbidity in 
people with diabetes and depression. Psychology & Health, 28, 103. 
doi:10.1080/08870446.2012.716438  
Melek, S. & Norris, D. (2008) Millman research report: Chronic conditions and comorbid 
psychological disorders. Seattle, WA: Milliman. 
Mercer, S. W., Smith, S. M., Wyke, S., O'Dowd, T., & Watt, G. C. (2009). Multimorbidity 
in primary care: Developing the research agenda, Family Practice, 26, 79-80. 
doi:10.1093/fampra/cmp020  
Mezuk, B., Eaton, W. W., Albrecht, S., & Golden, S. H. (2008). Depression and type 2 
diabetes over the lifespan a meta-analysis. Diabetes Care, 31, 2383-2390. doi: 
10.2337/dc08-0985  
Michie, S., Abraham, C., Whittington, C., McAteer, J., Gupta, S. (2009). Effective 
techniques in healthy eating and physical activity interventions: A meta-
regression. Health Psychology, 28, 690-701. doi: 10.1037/a0016136  
Mokdad A. H., Marks J. S., Stroup J. S., Gerberding J.L. (2004). Actual causes of death 
in the United States, 2000. Journal of the American Medical Association, 291, 
1238-1245. doi: 10.1001/jama.291.10.1238  
Morisky, D. E., Ang, A., Krousel-Wood, M., & Ward, H. J. (2008). Predictive validity of a 
medication adherence measure in an outpatient setting. The Journal of Clinical 
Hypertension, 10, 348-354. doi:10.1111/j.1751-7176.2008.07572.x  
Morrow, D., Clark, D., Tu, W., Wu, J., Weiner, M., Steinley, D., & Murray, M. D. (2006). 
Correlates of health literacy in patients with chronic heart failure. The 
Gerontologist, 46, 669-676. doi: 10.1093/geront/46.5.669  
Murphy B., Herrman H., Hawthorne G., Pinzone T., & Evert H. (2000). Australian 
WHOQoL instruments: User’s manual and interpretation guide. Australian 
WHOQoL Field Study Centre, Melbourne, Australia. 
National Institutes of Health, U.S. Department of Health and Human Services, Public 
Health Service, National Cancer Insittute, (1994). Clear and simple: Developing 
effective print materials. NIH Publications #95-3594. Available at 
http://devcompage.com/wp-content/uploads/2010/12/Clear_n_Simple.pdf 
Nace, D. K., Nielsen, M., & Grundy, P. (2012). The Patient Centered Medical Home: 
Integrating Comprehensive Medication Management to Optimize Patient 
Outcomes. (2nd ed.) Washington D.C.: Patient-Centered Primary Care 





Nilsen, W. J., & Olster, D. H., (2013). News from NIH: Effective behavioral treatments 
for patients with multiple chronic conditions. Translational Behavioral Medicine, 3, 
1-2. doi: 10.1007/s13142-012-0184-x  
Noel, P., Williams, J., Unutzer, J., Worchel, J., Lee, S., Cornell, J., . . . Harpole, L. 
(2004). Depression and comorbid illness in elderly primary care patients: Impact 
on multiple domains of health status and well-being. Annals of Family Medicine, 
2, 555-562. doi: 10.1370/afm.143  
Norman, G. R., Sloan. J. A., & Wyrwich, K. W. (2003). Interpretation of changes in 
health-related quality of life: The remarkable universality of half a standard 
deviation. Medical Care, 41, 46-57. doi: 10.1097/01.mlr.0000062554.74615.4c  
Nutbeam, D. (2000). Health literacy as a public health goal: A challenge for 
contemporary health education and communication strategies into the 21st 
century. Health Promotion International, 15, 259-267. doi: 
10.1093/heapro/15.3.259  
Ogedegbe, G., Mancuso, C. A., Allegrante, J. P., & Charlson, M. E. (2003). 
Development and evaluation of a medication adherence self-efficacy scale in 
hypertensive African American patients. Journal of Clinical Epidemiology, 56, 
520-529. doi: 10.1016/s0895-4356(03)00053-2  
Oldridge, N. B., Stump, T. E., Nothwehr, F. K., & Clark, D. O. (2001). Prevalence and 
outcomes of comorbid metabolic and cardiovascular conditions in middle- and 
older-age adults. Journal of Clinical Epidemiology, 54, 928-934. doi: 
10.1016/s0895-4356(01)00350-x  
Osterberg, L., & Blaschke, T. (2005). Adherence to medication. New England Journal of 
Medicine, 353, 487-497. doi: 10.1056/nejmra050100  
Paharia, M. I. (2008). Chronic disease prevention. In Boyer, B. A., & Paharia, M. I. 
(Eds.). Comprehensive handbook of clinical health psychology (55-80). Hoboken, 
NJ: Wiley. 
Parekh, A. K., & Goodman, R. A. (2013). The HHS strategic framework on multiple 
chronic conditions: genesis and focus on research. Journal of Comorbidity, 3(2), 
22-29. 
Perri, M. G., Nezu, A. M., McKelvey, W. F., Shermer, R. L., Renjilian, D. A., & Viegener, 
B. J. (2001). Relapse prevention training and problem-solving therapy in the 
long-term management of obesity. Journal of Consulting and Clinical Psychology, 
69, 722-726. doi:10.1037/0022-006X.69.4.722  
Plack, Herpertz, Petrak, (2010), Behavioral medicine interventions in diabetes. Current 




Radloff, L. S. (1977). The CES-D scale: A self-report depression scale for research in 
the general population. Applied Psychological Measurement, 1, 385-401. doi: 
10.1177/014662167700100306  
Reeves, M. J., Rafferty, A. P. (2005). Healthy lifestyle characteristics among adults in 
the United States, 2000. Archives of Internal Medicine, 165, 854–857. doi: 
10.1016/j.accreview.2005.08.022  
Roter, D. L., Hall, J. A., Merisca, R., Nordstrom, B., Cretin, D., & Svarstad, B. (1998). 
Effectiveness of interventions to improve patient compliance: A meta-analysis. 
Medical Care, 36, 1138-1161. doi: 10.1097/00005650-199808000-00004  
Rothman, R. L., DeWalt, D. A., Malone, R., Bryant, B., Shintani, A., Crigler, B., . . . 
Pignone, M. (2004). Influence of patient literacy on the effectiveness of a primary 
care-based diabetes disease management program. The Journal of the 
American Medical Association, 292, 1711-1716. doi:10.1001/jama.292.14.1711  
Rothman, A., & Wagner, E. H. (2003). Chronic illness management: What is the role of 
primary care? Annals of Internal Medicine, 138, 256. doi: 10.7326/0003-4819-
138-3-200302040-00034  
Rubin, R. (2005). Adherence to pharmacologic therapy in patients with type 2 diabetes 
mellitus. American Journal of Medicine, 45, 151-159. doi: 
10.1016/j.amjmed.2005.04.012  
Sabate, E. (2003). Adherence to long-term therapies: Evidence for action. Geneva, 
Switzerland: World Health Organization. 
Sarkar, U., Fisher, L., Schillinger, D. (2006). Is self-efficacy associated with diabetes in 
self-management across race/ethnicity and health literacy? Diabetes Care, 29, 
823-829. doi: 10.2337/diacare.29.04.06.dc05-1615  
Sbrocco, T., Nedegaard, R. C., Stone, J. M., & Lewis, E. L. (1999). Behavioral choice 
treatment promotes continuing weight loss: Preliminary results of a cognitive-
behavioral decision-based treatment for obesity. Journal of Consulting and 
Clinical Psychology, 67, 260-266. doi:10.1037/0022-006X.67.2.260  
Schoenthaler, A., Ogedegbe, G., & Allegrante, J. P. (2009). Self-efficacy mediates the 
relationship between depressive symptoms and medication adherence among 
hypertensive African Americans. Health Education & Behavior, 36, 127-137. doi: 
10.1177/1090198107309459  
Schroeder, S. A. (2007). We can do better – improving the health of the American 





Shi, L., Lebrun-Harris, L. A., Daly, C. A., Sharma, R., Sripipatana, A., Hayashi, A. S., & 
Ngo-Metzger, Q. (2013). Reducing disparities in access to primary care and 
patient satisfaction with care: The role of health centers. Journal of Health Care 
for the Poor and Underserved, 24, 56-66. doi: 10.1353/hpu.2013.0022  
Skevington, S. M. & McCrate, F. M. (2012). Expecting a good quality of life in health: 
Assessing people with diverse diseases and conditions using the WHOQOL-
BREF. Health Expectations, 15, 49–62. doi: 10.1111/j.1369-7625.2010.00650.x 
Smith, S. M., Soubhi, H., Fortin, M., Hudon, C., & O'Dowd, T. (2012). Interventions for 
improving outcomes in patients with multimorbidity in primary care and 
community settings. Cochrane Database of Systematic Reviews, 4. 
doi:10.1002/14651858.CD006560.pub2  
Smith, S. K., Nutbeam, D., & McCaffery, K. J. (2013). Insights into the concept and 
measurement of health literacy from a study of shared decision-making in a low 
literacy population. Journal of Health Psychology, 18, 1011-1022. 
doi:10.1177/1359105312468192  
Spijkerman, T., de Jonge, P., van den Brink, R. H., Jansen, J. H., May, J. F., Crijns, H. 
J., & Ormel, J. (2005). Depression following myocardial infarction: First-ever 
versus ongoing and recurrent episodes. General Hospital Psychiatry, 27, 411-
417. doi: 10.1016/j.genhosppsych.2005.05.007  
Starfield, B. (2011). Challenges to primary care from co- and multi-morbidity. Primary 
Health Care Research & Development, 12, 1. doi:10.1017/S1463423610000484  
Stuart B. & Briesacher B. (2002). Medication decisions – right and wrong. Medical Care 
Research and Review, 59, 123–145. doi: 10.1177/1077558702059002001  
Sullivan, P., Mark D., O'Connor, P., Feeney, P., Hire, D., Simmons, . . . Katon, W. J., 
(2012). Depression predicts all-cause mortality: Epidemiological evaluation from 
the ACCORD HRQL substudy. Diabetes Care, 35, 1708-15. doi: 10.2337/dc11-
1791  
 Taylor, J. (2004). The fundamentals of community health centers. National Health 
Policy Forum, Washington D.C. 
Thorpe, C. T., Bryson, C. L., Maciejewski, M. L., & Bosworth, H. B. (2009). Medication 
acquisition and self-reported adherence in veterans with hypertension. Medical 
Care, 47, 474-481. doi: 10.1097/mlr.0b013e31818e7d4d  
Townsend, A., Hunt, K., & Wyke, S. (2003). Managing multiple morbidity in mid-life: A 
qualitative study of attitudes to drug use. British Medical Journal, 327, 837-840.  




Tudor-Locke, C., Williams J. E., Reis, J. P., & Pluto, D. (2002). Utility of pedometers for 
assessing physical activity: Convergent validity. Sports Medicine, 32, 795-808. 
doi: 10.2165/00007256-200232120-00004  
Viswanathan, M., Golin, C. E., Jones, C. D., Ashok, M., Blalock, S. J., Wines, R. C. M., . 
. . Lohr, K. N. (2012). Interventions to improve adherence to self-administered 
medications for chronic diseases in the United States. Annals of Internal 
Medicine, 157, 785-795.  doi: 10.7326/0003-4819-157-11-201212040-00538  
von Wagner, C., Steptoe, A., Wolf, M. S., & Wardle, J. (2009). Health literacy and health 
actions: A review and a framework from health psychology. Health Education & 
Behavior, 36, 860-877. doi:10.1177/1090198108322819  
Webb, M. S., de Ybarra, D. R., Baker, E. A., Reis, I. M., & Carey, M. P. (2010). 
Cognitive–behavioral therapy to promote smoking cessation among African 
American smokers: A randomized clinical trial. Journal of Consulting and Clinical 
Psychology, 78, 24-33. doi: 10.1037/a0017669  
Weiss B. D., Maysm M. Z., Martz W., Castro K. M., DeWalt D. A., Pignone M. P., ! 
Hale F. A. Quick assessment of literacy in primary care: The newest vital sign. 
Annals of Family Medicine, 3, 514-522. doi: 10.1370/afm.405  
Williams, A., Manias, E., & Walker, R. (2008). Interventions to improve medication 
adherence in people with multiple chronic conditions: A systematic 
review. Journal of Advanced Nursing, 63, 132-143. doi: 10.1111/j.1365-
2648.2008.04656.x  
Wolff, J. L., Starfield, B., & Anderson, G. (2002). Prevalence, expenditures, and 
complications of multiple chronic conditions in the elderly. Annals of Internal 
Medicine, 162, 2269-2276. doi: 10.1001/archinte.162.20.2269  
Wysocki, T. (2006). Behavioral assessment and intervention in pediatric 
diabetes. Behavior Modification, 30, 72-92. doi: 10.1177/0145445505284275  
Appendix A: Institutional Review Board Approvals 
 




EAST  CAROLINA  UNIVERSITY 
University & Medical Center Institutional Review Board Office  
4N-70 Brody Medical Sciences Building" Mail Stop 682 
600 Moye Boulevard " Greenville, NC 27834 
Office 252-744-2914 " Fax 252-744-2284 " www.ecu.edu/irb 
 
Notification of Exempt Certification 
 
 
From: Social/Behavioral IRB 
To: Laura Daniels 
CC:  
Lisa Campbell 
Date: 11/30/2012  
Re: UMCIRB 12-001914  
Patient and Provider Survey of Chronic Disease Management Needs 
 
 
I am pleased to inform you that your research submission has been certified as exempt on 11/30/2012. This study is 
eligible for Exempt Certification under category #2. 
  
 
It is your responsibility to ensure that this research is conducted in the manner reported in your application and/or 
protocol, as well as being consistent with the ethical principles of the Belmont Report and your profession. 
This research study does not require any additional interaction with the UMCIRB unless there are proposed changes 
to this study. Any change, prior to implementing that change, must be submitted to the UMCIRB for review and 
approval. The UMCIRB will determine if the change impacts the eligibility of the research for exempt status. If more 
substantive review is required, you will be notified within five business days. 
The UMCIRB office will hold your exemption application for a period of five years from the date of this letter. If you 
wish to continue this protocol beyond this period, you will need to submit an Exemption Certification request at least 
30 days before the end of the five year period. 
The Chairperson (or designee) does not have a potential for conflict of interest on this study. 
 
   
IRB00000705 East Carolina U IRB #1 (Biomedical) IORG0000418 











EAST  CAROLINA  UNIVERSITY 
University & Medical Center Institutional Review Board Office  
4N-70 Brody Medical Sciences Building" Mail Stop 682 
600 Moye Boulevard " Greenville, NC 27834 
Office 252-744-2914  " Fax 252-744-2284  " www.ecu.edu/irb 
 
Notification of Initial Approval: Expedited 
 
From: Social/Behavioral IRB 
To: Laura Daniels 
CC:  
Lisa Campbell  
Laura Daniels 
Date: 11/25/2013  
Re: UMCIRB 13-001992  
Pilot Intervention for Medication Adherence with Patients with MCC 
 
I am pleased to inform you that your Expedited Application was approved. Approval of the study and any consent 
form(s) is for the period of 11/22/2013 to 11/21/2014. The research study is eligible for review under expedited 
category #7. The Chairperson (or designee) deemed this study no more than minimal risk. 
 
Changes to this approved research may not be initiated without UMCIRB review except when necessary to eliminate 
an apparent immediate hazard to the participant.  All unanticipated problems involving risks to participants and others 
must be promptly reported to the UMCIRB.  The investigator must submit a continuing review/closure application to 
the UMCIRB prior to the date of study expiration.  The Investigator must adhere to all reporting requirements for this 
study. 
 
Approved consent documents with the IRB approval date stamped on the document should be used to consent 
participants (consent documents with the IRB approval date stamp are found under the Documents tab in the study 
workspace). 
 
The approval includes the following items: 
 
Name Description 
Chronic disease self-efficacy scale_Stanford.docx Surveys and Questionnaires 
Daniels Dissertation Proposal_Committee Document.docx Study Protocol or Grant Application 
Demographic Questionnaire.docx Data Collection Sheet 
Demographic Questionnaire.docx Surveys and Questionnaires 
Health Problem Solving Scale & Scoring.docx Surveys and Questionnaires 
Informed Consent_Medication Adherence for MCC_Final.docx Consent Forms 
Med Ad_phone flyer.pub Recruitment Documents/Scripts 
Med Ad_Recruitment Handout_blue (1).pub Recruitment Documents/Scripts 
Medication Self-efficacy Scale_MASES.docx Surveys and Questionnaires 
Morisky Medication Adherence Scale_Scoring.pdf Surveys and Questionnaires 




TOFHLA - Large Print Version.pdf Surveys and Questionnaires 
WHO Quality of Life.docx Surveys and Questionnaires 
 
The Chairperson (or designee) does not have a potential for conflict of interest on this study. 
 
   
IRB00000705 East Carolina U IRB #1 (Biomedical) IORG0000418 
IRB00003781 East Carolina U IRB #2 (Behavioral/SS) IORG0000418 
 
 
!Appendix B: Patient and Provider Surveys 
Created by: Laura Daniels, MA 
 
Chronic Disease Management Program Topics:  Health Care Team Survey 
 
Please complete the following anonymous survey 
 
1. What is your role at KCHC?  
  ! Provider  ! CMA ! Other (indicate role):___________________ 
 
2. What are the most important things your patients can do to improve management of their 
health care?  
 
Choose up to 3
 Medication adherence 
 Symptom self-monitoring 
 Lifestyle modifications 
 Weight management 
 Pain Management  
 Managing comorbid chronic diseases 
 Communicate with provider 
 Other: ______________________ 
 
3. Patient communication with their health care team plays a role in managing one’s health. Would 
you like your patients to improve communication on any of the following topics?  
! Yes (Choose 2 below)  ! No (Proceed to question 3) 
 
 Challenges in keeping appointments 
 Discussing symptom side-effects, symptom changes 
 Contacting provider between appointments 
 Engaging in shared decision-making (e.g. collaborating on personal health care goals or 
medication regimen 
 Other: ________________________________________________________ 
 
4. Regarding patients’ psychosocial barriers for managing chronic conditions, which areas do 
patients need the most support?  
 
Choose up to 3 
 Emotional distress 
 Distress about health  
 Work stress 
 Stress related to daily tasks or 
responsibilities 
 Spouse-Partner relationship 
 Family relationships 
 Other: ____________________ 
!++)!!
 
5. If your patient participated in a chronic disease self-management program, would you like 
updates on their progress or health-related goals? 
! Yes (see question 6)   ! No 
 
6. What would be your preferred method of receiving an update on your patient’s goals?    
Choose up to 2 
 Brief summary in paper format 
 Brief note in the patient’s EMR  
 Face-to-face update from program coordinator 
 Face-to-face update from patient 




Chronic Disease Management:  Patient Survey 
 
Please complete the following anonymous survey 
 




 Heart disease 
 Obesity 
 High blood pressure 
 Asthma 
 Depression/Anxiety 
 High cholesterol 
 Borderline diabetes 
 Chronic Pain 
 Sleep problems 
 
2. What are the most important things that you want to do or learn to improve your 
health? Choose up to 3 
 
 Taking medication as 
prescribed  
 Monitoring symptoms 
 Making lifestyle changes 
 Managing weight/weight loss 
 Managing pain  
 Managing multiple chronic 
diseases 
 Communicating with provide
!++"!!
 
3. Patient communication with their health care team plays a role in managing 
one’s health. Would you like to improve communication with your doctor on 
any of the following topics?  
 
! Yes (Choose up to 2 below)  ! No (Proceed to question 4) 
 
 Discussing challenges in keeping appointments 
 Discussing symptom side-effects, symptom changes 
 Contacting provider between appointments 
 Setting specific goals for improving my health 
 
4. Sometimes our own thoughts, feelings, or lifestyle choices make it difficult 
to make healthy changes. Other times it is something or someone in our 
environment.  Which of the following topics make it difficult for you to 
manage your health or are impacted by your health condition?  
 
Choose up to 3  
 Emotional distress  
 Distress about health  
 Work stress 
 Stress related to daily tasks or responsibilities 
 Spouse-Partner relationship 
 Family relationship 
5. If you were participating in a chronic disease self-management program, 
would you want your provider to be updated on your progress or health 
goals? 
! Yes (see question 6)  ! No 
 
!++#!!
6. How would you like your provider updated on your progress or goals if you 
participated in a health program?   Choose up to 2 
 
 Update in your health record  
 Face-to-face update from program coordinator 
 I would like to update my doctor during my visit 
 Other: _________________________________
!Appendix C: Session-by-Session Outline 
 
Enrollment Session 
1. Informed Consent 
2. Baseline assessment  
a. Demographics (participant number, name, sex, age, race/ethnicity phone 
number, address, birth date, education, Rx assistance) 
b. Chronic conditions (type, number) 
c. Medications (type, number) 
d. Primary and secondary outcomes assessment 
3. Introduction to program materials 
4. Obtain from EMR current medications list. 
5. Homework: Prior to first group meeting participant should use this list to verify 
medication list at home and bring to first group meeting. 
6. If necessary, refer to Medication Assistance Program. 
 
Session 1: Overview and Self-monitoring 
! Handouts/materials 
1. Gas cards 
2. Overview of program philosophy and objectives handout 
3. Self-monitoring log worksheet (2) 
4. Goal-setting action plan worksheet 
 
1. Welcome and introductions (10 min) 
2. Program overview (10 min) 
a. Philosophy: Enhancing knowledge and skills for taking medications and 
overcoming challenges to adherence using a small change approach 
b. Group rules and expectations 
c. Basic agenda for sessions 
3. Group discussion: Medication concerns, challenges (15 min) 
4. Didactic (20 min):  
a. Self-monitoring - obtaining a baseline (10 min) 
b. Goal-setting - setting small goals and creating an action plan (10 min) 
5. Activities (25-30 min): 
a. Decisional balance for taking medications will occur after group discussion (5 
min) 
b. Complete a sample self-monitoring log during didactic component (10 min) 
c. Setting first small change goal during didactic component (10 min) 
6. Goals-setting and homework (5 min):  
a. Homework: Begin self-monitoring 
b. Small Change Goal: Number of days self-monitoring 
c. Handout gas cards 
 
Session 2: Taking Control of Your Medication Schedule 
! Handouts/materials 
1. Personal pill organizer 
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2. Example prescription bottle and information leaflet 
3. Dosing schedule worksheet 
4. Self-monitoring log 
5. Goals-setting action plan worksheet 
 
1. Welcome back and overview of session agenda (2 min) 
2. Check-in: successes and challenges in self-monitoring and report baseline self-
monitoring  (10 min) 
3. Discussion (10 min): 
a. What did you learn about your patterns?  
b. When is it easy/hard to remember to take medications? 
c. What medications are difficult/easy to adhere to? 
d. Issues of control of one’s schedule? 
4. Didactic: Health Literacy (28 min) 
a. Interpreting prescription information and dosing recommendations (15 min) 
b. Simplifying the dosing schedule using a model schedule (10 min) 
c. Prescription changes: Not if, but when (3 min) 
5. Activities (25 min): 
a. Interpreting a sample prescription instructions and information leaflet include 
with didactic component 
b. Creating an individualized dosing schedule include with didactic component 
(10 min) 
c. Filling your pill organizer (15 min) 
6. Group discussion: Reflections on completed dosing schedule (5 min) 
7. Goal-setting and Homework (10 min):  
a. Homework: continue self-monitoring self-selected medications based on 
check-in discussion. 
b. Small Change Goal: Focus on improving adherence for one medication  
 
Session 3: Tools for Success: Your Attitude  
! Handouts/materials 
1. Tools for Success: Your Attitude/ABC handout  
2. ABC worksheet (2) 
3. Self-monitoring Log 
4. Goal-setting Action Plan worksheet  
 
1. Welcome back and overview of session agenda (2 min) 
2. Check-in: Successes/challenges with achieving goal, collect weekly adherence data 
(15 min) 
3. Discussion (10 min):  
a. What did you learn about yourself while working on this goal?  
b. What problems arose?  
c. How did the pill organizer help? 
4. Didactic: Tools for Success (19 min) 
a. Case Example: Negative Ned (or group member example from check-in) (2 
min) 
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b. Case Example: Positive Pat (or group member example from check-in) (2 
min) 
c. ABC approach to dealing with problems (15 min) 
5. Discussion (15 min):  
a. Differences in Ned and Pat’s antecedents, behaviors, and consequences? (3 
min)  
b. Reflections on the ABC approach. How aware are you of the ABC’s when 
you miss a dose/avoid a dose? (10 min) 
c. Can you see your self trying out this approach to understanding problems? 
(2 min) 
6. Activity: Complete ABC worksheet for case examples (or personal example) (10 
min) 
7. Goal-setting and Homework: 
a. Homework: Continue self-monitoring. 
b. Small Change Goal: Modify last weeks goal, maintain goal, or add another 
medication goal? 
c. Homework: Complete ABC worksheet with problem (e.g. missed dose 
occurs) 
 
Session 4: Tools For Success: Your Actions 
! Handouts/materials 
1. Tools for Success: Your Actions/Problem-solving Skills handout 
2. Problem-solving worksheet 
3. Self-monitoring Log 
4. Goal-setting Action Plan worksheet 
 
1. Welcome back and overview of session agenda (2 min) 
2. Check-in: Successes/challenges to achieving goal, collect adherence data (10 min) 
3. Discussion (15 min):  
a. What problems make it difficult to take your medications?  
b. Ask if anyone is willing to share their ABC experience?  
c. What other problems have you learned that affect adherence? Side effects? 
Beliefs about medications? 
4. Didactic: Tools for Success (19 min) 
a. Case example: Avoidant Angie (or group member example) (2 min) 
b. Case example: Productive Pat (or group member example) (2 min) 
c. Problem solving skills training (15 min) 
5. Discussion (18 min):  
a. Differences in Angie and Pat’s approach and outcomes (5 min) 
b. Reflections on the problem solving process. How do you overcome 
problems? How do you get back to taking medications regularly? (10 min) 
c. Can you see yourself trying out this approach to solving problems? (3 min) 
6. Activity: Complete problem-solving worksheet for case example and personal 
example (15 min) 
7. Goal-setting and Homework (2 min): 
a. Homework: continue self-monitoring 
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b. Small Change Goal: Modify last weeks goal, maintain goal, or add another 
goal? 
c. Homework: Complete problem-solving worksheet for one problem this week. 
8. Last session reflection (5 min) 
9. Preview for phone meeting and sign-up for individual session times (5 min) 
 
Phone Session 1:  
! Handouts/materials 
1. Tools for Success: Your Attitude and Your Action worksheet 
2. Self-monitoring Log 
3. Goal-setting Action Plan worksheet 
 
1. Check-in (8 min):  
a. Successes/challenges in meeting goal  
b. Collect adherence data 
c. Review problem-solving efforts 
2. Discussion with feedback (5-10 min): 
a. What was difficult about using the problem solving skills? 
b. What other problems came up? 
3. Individualized Activity: ABC or Problem-solving skills Worksheet (10 min) 
4. Goal-setting and Homework (5 min): 
a. Homework: continue self-monitoring 
b. Small Change Goal: Modify last weeks goal, maintain goal, or add another 
medication goal? 
c. Homework: Complete problem-solving worksheet for one problem. 
 
Phone Session 2: 
! Handouts/materials 
1. Future problems worksheet 
2. Self-monitoring Log 
3. Goal-setting Action Plan worksheet 
 
1. Check-in (8 min):  
a. Success/challenges in meeting goals  
b. Collect adherence data 
c. Problem-solving experience 
2. Discussion with feedback (5-10 min): 
a. What have you learned over the past few weeks about the challenges in 
taking medications as prescribed? 
b. What have you learned helps with improving your adherence? 
3. Individualized Activity: Identifying future problems (10 min). 
4. Goal-setting and Homework (5 min): 
a. Homework: Continue self-monitoring 
b. Small Change Goal: Modify last weeks goal, maintain goal, or add another 
goal? 
c. Schedule post treatment session 
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Post-treatment Individual Meeting and Assessment 
1. Solicit personal reflection of program 
2. Collect post-treatment primary and secondary outcome data 
3. Provide progress chart of medication adherence  
4. Provide gas card 
